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Pre-mRNA splicing is an essential eukaryotic pathway which controls gene 
expression. Increasing lines of evidence indicate links between splicing and other 
RNA processing pathways such as chromatin remodeling, transcription and 3’end 
processing, yet in many cases the specific proteins responsible for functionally 
connecting these pathways remain unclear.  
To determine the full complement of factors which impact pre-mRNA splicing, I 
developed a genome-wide screen in Saccharomyces cerevisiae which allowed me to 
evaluate differences in splicing efficiency in the background of ~5500 unique gene 
mutations. By measuring expression changes in precursor levels by high-throughput 
quantitative PCR, I detected enrichment in several classes of genes, with very strong 
candidates mapping to the chromatin remodeling, transcription and 3’end processing 
classes. One of these candidates is the bromodomain protein Bdf1, a component of the 
transcription factor TFIID and also a member of the SWR-C chromatin remodeling 
complex. Splicing sensitive microarrays confirm that deletion of Bdf1 leads to a global 
splicing defect, while ChIP-qPCR data reveal a decrease in U1 snRNP recruitment at 
intron containing genes, suggesting an inhibitory effect on spliceosome assembly. 
 Conversely, Bdf1’s homologue Bdf2 with which it is 46% identical, does not impact 
pre-mRNA splicing or spliceosome recruitment, consistent with my hypothesis that 
Bdf2 functions mainly in transcription.  
To further characterize Bdf1 function, I modified the high-throughput screening 
approach described above and employed it in a forward genetic manner to enable a 
mutagenic analysis of the Bdf1 protein. This analysis revealed that the C-terminal tail 
which overlaps with the Taf7 interaction domain, and contains a conserved SEED 
region and one of the known phosphorylation sites in Bdf1, may be responsible for the 
splicing defect. 
In opposition to the global splicing defect exhibited by Bdf1, mutations in 3'end 
processing factors such as Cft2 and Yth1 result in transcript-specific defects. My 
results highlight the cross-talk between 5’ and 3’end processing factors and the 
spliceosome, and support a model in which the definition of terminal exons in the 
budding yeast is identical with the mechanism described in higher systems.  
Furthermore, the novel role of Bdf1 at the interface of transcription and pre-mRNA 
splicing suggests a new mechanism that underlies the coupling between these two 
RNA pathways.  
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CHAPTER 1 
 
INTRODUCTION: PRE-mRNA SPLICING AND ITS CONNECTIONS TO OTHER 
RNA PROCESSING PATHWAYS 
 
1.1 Introduction 
 
Pre-mRNA splicing is a major step in the processing of eukaryotic RNA precursor 
molecules which removes non-coding intervening sequences (introns) from the mature 
transcript and ligates the coding fragments (exons) together. The process consists of 
two subsequent transesterification reactions and is catalyzed by a massive 
macromolecular complex known as the spliceosome which includes 5 small nuclear 
RNAs (snRNAs) –U1, U2, U4, U5, U6 - and over 100 proteins. Whereas the snRNAs 
are thought to make up the catalytic core of the spliceosome [1], the proteins can be 
stably associated with the U1-U5 molecules forming small nuclear ribonucleoprotein 
(snRNP) particles, they can interact with the substrate or mediate the assembly of 
other spliceosomal factors, or can function as molecular motors which guide the 
rearrangements which take place at different steps in the splicing process (helicases, 
ATPases).  
The splicing of a single precursor RNA molecule is a highly regulated process and 
requires the ordered assembly of several complexes at the level of the substrate. The 
substrate itself displays several conserved sequences which are specifically recognized 
such as the 5’ splice site, the branchpoint, the 3’splice site and, in the case of higher 
systems the polypyrimidine tract (see Figure 1.1A and [2]  for review) . Moreover, a 
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breadth of auxiliary SR proteins is known to act in higher systems to guide substrate 
recognition through interaction with splicing silencers and enhancers and influence 
alternative splicing decisions.  
 
Figure 1.1: Intronic recognition sequences and the splicing cycle [2] 
 
In the splicing cycle, the U1snRNP first base pairs with the 5’ splice site and the 
branch point recognition protein (BBP in yeast or SF1 in higher systems) binds the 
adenosine residue which will later participate in the first transesterification reaction. In 
addition, in higher systems the U2 auxiliary factor (U2AF) which consists of two 
subunits assembles at level of the polypyrimidine tract (through U2AF65), and at the 
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3’ splice site (though U2AF35). This leads to the formation of the early complex or 
complex E which does not require ATP hydrolysis. Next, the U2 snRNP recognizes 
the branch point adenosine in an ATP-dependent fashion, displacing SF1/BBP and 
leads to the formation of the A complex. The U4/U5/U6 tri-snRNP is then recruited to 
the substrate, forming complex B, but this complex is not yet catalytically active. For 
this to occur, several rearrangements must take place which will allow for the 
formation of a base-pairing interaction between U2 and U6, thus creating the catalytic 
core of the spliceosome, and lead to the exclusion of U1 and U4 snRNPs from the 
complex (Figure 1.1B). The activated spliceosome, also known as complex B*, can 
now catalyze the first transesterification reaction in which the branch point adenosine 
attacks the phophodiester bond at the 5’ splice site. This leads to the formation of a 
free 5’exon and a second lariat-3’exon product and represents the spliceosomal 
complex C. Finally, the second transesterification reaction occurs when the 3'-
hydroxyl on the free exon attacks the phosphodiester bond at the 3’ splice site and 
leads to the ligation of the two exons and the release of a circular lariat. Following this 
step, the spliceosome is disassembled and its subunits are recycled.  
Historically, pre-mRNA splicing was studied in isolation from other RNA processing 
pathways. Nevertheless, a growing body of evidence has made it clear that cellular 
RNA processing pathways are very tightly interconnected. In the following sections, I 
will focus on several lines of evidence which link pre-mRNA splicing to the 
processing steps at the 5’end of the gene such as chromatin remodeling and 
transcription, as well as to the ones which occur at the 3’end: cleavage and 
polyadenylation. 
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1.2 Splicing and chromatin  
Several recent studies have started to shed light on a connection between pre-mRNA 
splicing, nucleosome localization and chromatin marks [3-10]. Thus, the analysis of 
genome-wide nucleosome positioning and chromatin modification datasets from 
mammals, mouse, worms and flies has identified a strong correlation between 
nucleosome occupancy and internal exons, which is independent of their expression 
levels and is not a consequence of a higher GC content associated with coding regions. 
Nucleosomes appear to mark true exons, since they are depleted from pseudoexons in 
spite of their strong splice sites. In addition, there is an inverse correlation between the 
strength of the splice sites flanking the exons and nucleosome occupancy, which also 
correlates with exon inclusion [5]. This led to the hypothesis that nucleosomes are 
important for alternative splicing decisions and that they act as “speed bumps” since 
they have been shown to slow down RNA polymerase II elongation [11,12] and 
increase pausing. A slowed polymerase would allow for a “window of opportunity” in 
which the spliceosome can recognize suboptimal splice sites around constitutive exons 
and include them in the final spliced product.  
Moreover, exons, but not introns, were found to be enriched in specific chromatin 
marks such as H3K36me3, K3K27me1, K3K27me2 or K3K27me3, H4K20me1, 
H3K79me1, H2BK5me1 [3]. Among these chromatin marks, H3K36me3 levels 
correlate with exon inclusion, are dependent on transcription and are enriched in the 3’ 
portions of the genes [10]. One of the most interesting studies which showed a direct 
mechanism through which the H3K36me3 mark can influence alternative splicing 
decisions is the Luco et al. study [13].  In this study, the FGFR2 reporter gene was 
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monitored, in which exons IIIb and IIIc are alternatively spliced. H3K36me3 levels 
are increased in hMSC cells in which exon IIIb is excluded and decreased in PNT2 
cells in which this exon is included. Interestingly, overexpression of the H3K36me3 
methyltransferase Set2 [14,15] drives exon IIIb repression in PNT2 cells.. The 
exclusion of exon IIIb was shown to be dependent on MRG15, an adaptor protein 
which recognizes the H3K36me3 mark and physically interacts with PTB, the 
polypyrimidine tract binding protein which represses exon IIIb (Figure 1.2). This is 
the first example of an adapter system which can guide alternative splicing outcomes 
based on direct recognition of chromatin marks.   
 
Figure 1.2: Modulation of splicing by H3K36me3 [16] 
Further evidence which supports H3K36me3’s link with splicing comes from a 
separate study [17] which showed that mutating the 3’SS in the second intron of a β-
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globin reporter gene leads to a 3’ shift in the H3K36me3 distribution on intron-
containing genes. In addition, inhibiting splicing globally with spliceostatin A, (which 
blocks assembly after U2 binding) leads to the redistribution of the H3K36me3 mark 
in the same manner. Moreover, the Almeida et al. study [18] showed that the 
connection between the H3K36me3 chromatin mark deposition and splicing is 
bidirectional. Thus, inhibition of splicing with spliceostatin A inhibits SET2 
recruitment and decreases H3K36me3 levels. Therefore, the H3K36me3 mark whose 
deposition depends on the phosphorylation status of RNA polymerase II [15,19], 
active elongation and which marks exons for splicing, is in return controlled by the 
spliceosome. 
Besides the H3K36me3 mark, the H3K4me3 chromatin signature, which marks 
transcriptional starts sites, was shown to interact with CHD1 and change alternative 
splicing outcomes in vivo by regulating the interaction of U2snRNP with the substrate 
[20]. Moreover, interactions between U2snRNP and STAGA in human cells [21], a 
dependence on the Gcn5 HAT activity for the recruitment of U2snRNP components 
Lea1 and Msl1 [22], as well as synthetic lethal interactions between H2BK123ub1 and 
Lea1 and Msl1 in yeast [23] have been recently reported. 
Lastly, several reports suggest that the chromatin to splicing connection can be often 
mediated by SR proteins [24 review]. SR proteins were shown to interact with the 
phosphorylated C-terminal domain (CTD) of RNA polymerase II [25, 26] and couple 
splicing to transcription [27]. Thus, the HP1 protein which recognizes the H3K9me3 
mark was reported to coimmunoprecipitate with ASF/SF2 and hnRNP splicing 
repressors [28], while H3S10P regulates the interaction of SRp20 and ASF/SF2 with 
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mitotic chromosomes [29].  
In conclusion, several avenues connect splicing to chromatin marks and new ways of 
regulation and communication between the two are currently under investigation. 
 
1.3 Splicing and transcription 
The view of RNA polymerase II as a transcriptional toolbox which interacts with 
capping, splicing, and polyadenylation factors has become the accepted model in the 
RNA processing world (Figure1.3). The CTD of the polymerase interacts with a host 
of factors based on its different phosphorylation statuses and coordinates the 
transitions between initiation, active elongation and splicing, and termination and 
3’processing. 
 
Figure 1.3: RNA polymerase links the RNA processing machineries [16] 
Early EM studies [30] first observed co-transcriptional splicing on nascent transcripts 
in Drosophila. Today, the accepted view is that splicing reactions are initiated co-
transcriptionally [31] and that a significant proportion of them (80% in higher systems 
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[32]) are finalized before the polymerase dissociates from the transcript [33,34]. RNA 
polymerase II was observed to pause in terminal exons ~200 bp after the 3’splice site 
and ~150 bp before the polyA signal in yeast and allow for a 30-60 second temporal 
window in which splicing could be completed [33]. Curiously, the genes which were 
fully spliced co-transcriptionally had shorter terminal exons and longer introns on 
average than the ones that were not. Moreover, a precise kinetic study [35] showed 
that the pause at the level of the 3’ splice site is a cyclic process which coincides with 
the recruitment of splicing factors (U2, U5 snRNPs) and the first detection of spliced 
mRNA. RNA polymerase II pausing is splicing dependent and correlates with the Ser5 
phosphorylation mark on the CTD, whereas when the pause is released the 
phophorylation mark switches to Ser2. 
The positive feedback between splicing and transcription is supported by several lines 
of evidence, despite early in vitro studies that have shown that splicing and 
transcription can occur independently. Thus, gene expression is stimulated in the 
presence of an intron, and a 5’ splice site can independently stimulate transcription 
[36]. Moreover, the recruitment of U1 is dependent on transcription [37], whereas the 
recognition of a 5’splice by U1snRNP promotes productive reinitiation [38]. 
 
1.3.1 The CTD of RNA polymerase II and pre-mRNA splicing 
The coupling between transcription and pre-mRNA splicing involves the CTD of 
RNA polymerase II [39] in higher systems, since a deletion of the last 5 heptads in the 
CTD caused an inhibition of splicing and polyadenylation. It was further shown that 
the CTD phosporylation status was important for splicing stimulation [40, 41], while 
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the required domain was narrowed down to the last C-terminal 10 amino acids [42, 
43]. Lastly, a recent study revealed that the coupling consists in the interaction of 
U2AF65 with the phosphorylated CTD, followed by the recruitment of the Prp19 
complex through a physical interaction with U2AF65 [44]. Despite this however, it 
was recently shown that fusing the CTD onto a bacterial T7 polymerase or on RNA 
polymerase III does not enhance capping and splicing in vivo [45]. This could be due 
to promoter and 3’end processing differences between RNA polymerase II and these 
other polymerases, but might also suggest that the CTD is not sufficient for coupling 
transcription to splicing. 
In opposition to the evidence in higher systems, the yeast CTD was shown not to be 
required for the splicing of the RP51A mini-gene [46]. Even if this piece of evidence 
cannot be generalized, it still remains to be seen if such a connection can be 
established in yeast. So far, the main candidate for coupling splicing to transcription is 
Prp40 [47] which is a stable U1snRNP component that interacts with the 
phosphorylated CTD through its WW and FF domains. However, a deletion of the 
WW domains does not cause lethality and was recently shown [48] not to impact U1 
and U2 recruitment in vivo, but rather delay a later step of U5 recruitment. It remains 
to be seen if the yeast mechanism resembles the one in higher systems and if Prp40 is 
involved in this coupling.  
 
1.3.2 Capping and pre-mRNA splicing 
In addition to the coupling of splicing and transcription through the CTD of RNA 
polymerase II, numerous early studies have linked capping to splicing stimulation [49-
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57]. Thus, the presence of a 7-methyl GpppG cap on an RNA molecule promoted 
splicing in vivo and in vitro. Furthermore, GpppG but not ApppG cap analogs were 
able to compete with capped molecules in in vitro assays. Interestingly, the 
stimulatory effect on splicing was observed only for the first intron within a substrate 
and was negligible for subsequent introns [49, 54, 57].  
The splicing of a radiolabeled RNA precursor was also inhibited upon depletion of the 
cap-binding proteins CBC20 or CBC80 [50] in HeLa nuclear extracts, which 
correlated with a decrease in the rate of complex A formation. It was subsequently 
shown that the association of U1 with the 5’SS of the proximal intron is inefficient in 
extracts in which the cap binding complex has been depleted [57] and that both CBP 
proteins within the complex are required for efficient splicing stimulation. Support for 
this coupling was also found in yeast where Mud13, equivalent of mammalian CBP20, 
[58] exhibits synthetic lethality with a mutant allele of U1. Moreover, in a mud13Δ 
commitment complex formation is impaired. Lastly, additional interactions between 
nuclear cap binding proteins and hnRNPs [59] were described and shown to stimulate 
pre-mRNA splicing. 
 
1.3.3 Pre-mRNA splicing and transcription elongation: the kinetic model 
The RNA polymerase II elongation rate has been linked to alterative splicing choices. 
Thus, an increase in polymerase II elongation leads to increased skipping of exons 
with weaker splice sites, while a decrease in its rate is associated with higher 
alternative exon inclusion [60-64] see Figure 1.4)  
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Figure 1.4: The kinetic model: RNA polymerase II modulates alternative splicing 
[16] 
One of the first reports [60] engineered a slow polymerase and observed an increased 
inclusion of the EDI exon of the fibronectin gene. Moreover, in the case of the E1a 
adenovirus substrate in which three alternative 5’splice sites can be coupled to a single 
3’splice site, the slow polymerase caused the upstream 5’splice sites to be used more 
often. The reasoning behind this is that the transcription of the downstream preferred 
splice sites is delayed, and thus the spliceosome has time to recognize and act at the 
level of the suboptimal upstream splice sites. Similarly, a slow yeast RNA polymerase 
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(rpb2-10), as well as treatment with drugs which inhibit transcription elongation can 
suppress exon skipping in vivo and promote exon inclusion [65]. Furthermore, 
whereas inhibitors of transcription elongation increase exon inclusion, treatment with 
histone deacetylase inhibitors such as trichostatin A increase RNA polymerase II 
processivity and cause the opposite effect [62, 66]. Conversely, engineering of pause 
sites which delay the synthesis of repressive silencing elements in either the 
tropomyosin [67] or the FGFR2 [68] gene leads to the inclusion of the exon which is 
normally repressed.  
Finally, in addition to the elongation rate, splicing choices can also be dictated by the 
promoter [69], since an exchange of the α-1 globin promoter with a CMV promoter 
led to EDI inclusion. This effect was not correlated with the strength of the promoter 
and was also seen in with a mutant fibronectin promoter, suggesting that elements 
within the promoter can play a role in splicing. 
 
1.4 Splicing and 3’ end processing 
Given the toolbox model of RNA polymerase II, splicing and polyadenylation factors 
can interact and are brought together by the C-terminal domain of the polymerase. The 
CTD region of RNA polymerase II which is required for efficient cleavage and 
polyadenylation has been mapped [39, 42, 70] and it was shown [71] that the cleavage 
and polyadenylation specificity factor (CPSF) is recruited by TFIID and then 
transferred to the elongating polymerase.  
Connections between splicing and the cleavage and polyadenylation machinery are 
supported at multiple levels. Thus, antibodies against Sm and some U1 antisera inhibit 
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polyadenylation in vivo, while a mutation in the 3’ splice site of the β-globin 
intervening sequence IVS2 causes transcriptional read-through past the polyA site 
[72]. Moreover, early studies have shown that in coupled splicing and polyadenylation 
reactions mutating the polyA AAUAAA site to AAGAAA decreases the splicing of 
the terminal intron 5-10 fold [73], whereas mutating the 3’ splice site of the terminal 
intron leads to a 2-3 fold decrease in polyadenylation [74].  
 
Figure 1.5: Interactions between splicing of the terminal exon and the cleavage and 
polyadenylation machinery  [75] 
 
Several physical interactions (Figure1.5) between splicing factors and the cleavage 
and polyadenlyation have been described. Thus, The RS domain of U2AF65 
physically interacts with CFmI59 and promotes cleavage and polyadenylation [76], 
whereas physical interactions between the C-terminal end of polyA polymerase (PAP) 
and U2AF [77] stimulate U2AF binding to the upstream 3’ splice site. Furthermore, 
direct interactions between U2 snRNP (SF3a, SF3b) subunits and CPSF have been 
established [75], and shown to potentiate positive feedback between the two reactions. 
Moreover, the N-terminus of the U1snRNP protein U1A interacts with the 160kDA 
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subunit of CPSF and leads to increased polyadenylation in vitro [78], while the 25kDa 
CFIm subunit binds to U1 70K [79]. Ultimately, the Keller group has recently shown 
that an allele of the cleavage and polyadenylation factor Ysh1, ysh1-12, can 
specifically impact splicing [80], thus reinforcing the link between the two RNA 
processing pathways. 
 
1.5  The intron versus exon definition model 
Recognition of intronic and exonic sequences by the spliceosome follows the rule of 
assembly over the shortest distance. Thus, in higher systems where introns are large 
(from 1 to hundreds of kilobases) and the exons small (~150bp), the spliceosome 
recognizes the substrate by what is known as “exon definition”, in which the 
spliceosomal machinery assembles over the exon. In contrast, in budding yeast, the 
introns are small (with a median of ~150bp) whereas the exons are larger (with a 
median of ~450bp). In this case, the assembly of the spliceosome is thought to occur 
over the intron by following the “intron definition” model.  
 
Figure 1.6: The intron versus exon definition models [32] 
Several lines of evidence point to the different types of mechanisms that are used. 
Thus, in higher systems RNA substrates which contain complete exons only with a 
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preceding 3’ splice site and a downstream 5’ splice site can readily be integrated in 
spliceosomal A complexes in vitro [81]. Interestingly, the length of these units is 
critical, since exons longer than 300 bp are not recognized and this leads to the 
activation and usage of cryptic 3’splice sites in vivo. In addition, several studies have 
shown that short exons (<50bp) which make up about 4% of the human genome are 
usually skipped [82, 83], unless additional sequences such as strong polypyrimidine 
tracts are present upstream. Moreover, in HeLa cells, expanding the size of an exon 
from 18 to 109 bp leads to its constitutive inclusion, whereas the shortening of an exon 
to less than 50 bp leads to its skipping. Given that in higher systems the spliceosome 
assembles across an exon, the hypothesis is that recruitment of U1snRNP at the 5’ 
splice site of a downstream intron will recruit U2snRNP across the exon at the 
upstream 3’ splice site. This was shown experimentally, in that mutating the 5’ splice 
site in a multi-intron substrate, led to the inhibition of splicing of the upstream intron 
(for review [84]) and conversely, the strengthening of a weak 5’ splice site, increased 
the splicing of an upstream intron. Perhaps one of the "rules" of exon versus intron 
definition is the fact that mutation of a splice site in an exon that is governed by exon 
definition will lead to exon skipping, whereas the same mutation in an exon which 
follows the intron definition model will lead to intron retention.  
One case of particular interest regards the definition of terminal exons. The 5’ exon 
contains a 5’ splice site but no consensus sequence upstream that could aid in its 
definition. However, the 5’ end of the transcript is capped and it was shown that the 
presence of the cap enhances splicing (see section 1.3.2). Conversely, terminal exons 
which are larger than internal ones (~600bp), contain a 3’ splice site and a downstream 
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polyadenylation signal. As mentioned before, there is a bidirectional link between the 
splicing of the last intron and cleavage and polyadenylation, where a mutation in the 
polyadenylation signal inhibits the splicing of the upstream intron and the mutation in 
the 3’ splice site of this intron inhibits downstream cleavage and processing (see 
section 1.4). 
Interestingly, this model of terminal exon definition also applies in lower eukaryotes, 
even though internal introns are recognized by the intron definition model. In the body 
of this thesis, I will present a genome-wide screen which allowed me to map global 
cellular factors which impact pre-mRNA splicing. Aside from broadening our 
understanding of how splicing is connected to other RNA processing pathways within 
the cell, several of these mutants which impact pre-mRNA splicing reinforce this 
model of terminal exon definition and belong either to 5’ chromatin remodeling and 
transcription complexes, or the 3’ cleavage and polyadenylation machinery.  
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CHAPTER 2 
 
NOVEL CONNECTIONS BETWEEN PRE-mRNA SPLICING, 3’ AND 5’ END 
DETERMINANTS REVEALED BY A NOVEL HIGH-THROUGHPUT REVERSE 
GENETIC SCREEN
1
 
 
2.1 Introduction 
The coding portions of most eukaryotic genes are interrupted by non-coding introns 
which must be removed prior to the translation of their messenger RNAs (mRNA). 
Removal of introns from pre-mRNAs is catalyzed by the spliceosome, a large and 
dynamic ribonucleoprotein complex comprised of five small nuclear RNAs (snRNAs) 
and at least 100 proteins [1]. Much of our knowledge about the components that 
comprise the spliceosome as well as their mechanisms of action has been derived from 
experiments using the powerful genetic tools available in the budding yeast, 
Saccharomyces cerevisiae. Indeed, although the RNA2 – RNA11 genes originally 
identified in Hartwell’s forward genetic screen preceded the discovery of splicing [2], 
the mechanistic characterizations of these genes, since renamed PRP2 – PRP11, 
underlie current models of the splicing pathway. Importantly, because the core 
components of the spliceosome are highly conserved between budding yeast and 
humans, the mechanistic details derived from work in yeast have been instrumental in 
understanding mechanisms of pre-mRNA splicing in higher eukaryotes.  
The modern view of pre-mRNA splicing acknowledges the integrated role of the 
spliceosome with several other aspects of RNA processing. Whereas the historical 
                                                 
1
 Part of this chapter, including all tables and figures 2.1-2.13 and 2.15-2.16 have been published in 
Albulescu et al., PLoS. Genet. 2012. 
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view of splicing envisioned a cascade of temporal events initiated by transcription, 
followed by polyadenylation, and finalized with splicing and export of mRNAs from 
the nucleus, it is now clear that these pathways are not independent from one another 
but rather are functionally coupled. Strong evidence in both yeast and higher 
eukaryotes demonstrates that recruitment of the spliceosome to intron-containing 
transcripts occurs co-transcriptionally [3-6], mediated at least in part by physical 
associations between the C-terminal domain (CTD) of RNA polymerase II and the U1 
snRNP [7]. A growing body of evidence also indicates that the landscape of chromatin 
modifications encountered by transcribing polymerase molecules can dictate the 
activity of the spliceosome at various splice sites. For example, recent work has 
identified an enrichment of methylated lysine-36 in the histone H3 protein specifically 
within exonic sequences, suggesting a possible mechanism for facilitating the 
identification of intron-exon boundaries [8, 9]. Similarly, the rate of transcription by 
RNA polymerase II, which can be impacted by chromatin marks, has also been shown 
to be critical for dictating alternative splicing decisions [10]. Furthermore, it is also 
clear that splicing is coupled to down-stream steps in RNA processing. For example, 
the yeast Ysh1 protein [11, 12], which is the homolog of CPSF73, the mammalian 
endonuclease required for 3’ end processing, was originally identified as Brr5 in a 
cold-sensitive screen for mutants defective in pre-mRNA splicing [13]. Consistent 
with this observation, recent evidence suggests that transcriptional pausing near the 3’ 
end of genes is a critical component of pre-mRNA splicing efficiency [14]. Despite 
the increasing evidence of the interconnectivity of these pathways, in many cases the 
mechanistic details which underlie these functional relationships remain unclear. Our 
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understanding of these mechanistic connections would benefit from a more complete 
characterization of the complement of factors through which splicing is connected to 
these cellular processes. 
A variety of recent genome-wide approaches have provided important insights into the 
connections that exist between the spliceosome and other cellular processes. Two 
powerful approaches, Synthetic Genetic Array (SGA) Analysis [15] and Epistatic 
MiniArray Profiling (E-MAP) [16], leverage genetic tools available in yeast to 
systematically generate millions of double-mutant strains and then carefully quantitate 
their cellular fitness to determine an interaction score for every pair-wise mutation. On 
the basis of strong positive or negative genetic interaction scores these approaches 
have been successfully used to infer functional relationships between many cellular 
pathways, including several with pre-mRNA processing [17, 18]. Simultaneously, 
improvements in proteomic methodologies have enabled the direct analysis of protein 
complexes in organisms as diverse as humans and yeast, allowing for an assessment of 
all of the stably-bound proteins involved in pre-mRNA splicing in many organisms 
[19, 20]. While the combination of these and other approaches has provided a global 
picture of many of the cellular factors that influence the splicing pathway either 
directly or indirectly, an important question remains about the functional significance 
of these factors in the splicing of specific transcripts. Indeed, it has long been known 
that certain transcripts require the activity of unique accessory factors to facilitate their 
splicing [21]. Moreover, recent work supports the idea that different transcripts can 
have a greater or lesser dependence upon the activity of core spliceosomal components 
for their efficient splicing [22, 23]. 
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Here I present the results of a novel approach that complements the genetic and 
physical approaches of others by allowing for a direct functional assessment of nearly 
every gene in the S. cerevisiae genome in the pre-mRNA splicing process. For this 
work, I developed automated methods that enabled the isolation of total cellular RNA 
from about 5500 unique strains, each of which contained a mutation in a single gene, 
and all of which were examined during exponential growth in liquid medium. Using a 
high-throughput quantitative PCR (QPCR) assay, the relative cellular level of nearly 
any RNA can be readily determined in the background of each of these strains. By 
assessing the levels of several different pre-mRNA species, I was able to identify not 
only those factors which are necessary for the splicing of many transcripts, but also 
factors that are specifically required for the splicing of a subset of intron-containing 
genes. Whereas this study specifically examines the levels of several cellular pre-
mRNAs, the approach described herein can be easily adapted to study the level of 
nearly any RNA molecule of interest under a wide variety of cellular growth 
conditions.   
 
2.2 Materials and Methods 
2.2.1 High-throughput strain handling 
All experiments were performed using haploid strains. To assess the function of non-
essential genes, the mat a version of the haploid deletion library from Open 
Biosystems [55] was used (referred to herein as non-essential strains). Likewise, to 
assess the function of essential genes, a collection of strains provided by the Hieter lab 
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[25] was used (referred to herein as essential strains). In addition, a collection of 
strains containing previously characterized mutations in core spliceosomal 
components was used (from here on considered a part of the essential strains set). A 
complete list of the strains used in this work can be found online at 
http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1002530. Unless 
otherwise indicated, all strains were grown in rich medium supplemented with 2% 
glucose (YPD) [56]. When appropriate, strains were recovered from frozen glycerol 
stocks on solid medium supplemented with 200µg/ml G418 grown at either 30°C 
(non-essential strains) or 25°C (essential strains). A manual pinning tool (V&P 
Scientific, cat.#: VP384FP6) was used to transfer cells from solid medium into 384-
well microtiter plates (Greiner BioOne, cat.#: 781271) for growth in liquid media. 
Liquid cultures were grown in an Infors HT Multitron plate shaker at 900rpm with 
80% constant humidity. Breathable adhesive tape (VWR, cat.#: 60941-086) was used 
to seal the plates and reduce evaporation. 
Because the growth rates of the strains being used vary significantly [36], an approach 
was developed to enable the systematic collection of a similar number of rapidly 
dividing cells for each strain. An initial liquid culture was grown in 384-well plates for 
two days, allowing nearly all strains to reach saturation. Because all of the strains 
being used are derived from a common parental strain, the cell density for each of 
these strains is nearly identical at saturation, allowing us to effectively ‘normalize’ the 
cell numbers. Using a liquid handling robot (Biomek NX), 2 µl of saturated culture 
were used to inoculate a fresh 150 µl of YPD. This culture was allowed to grow for 
four hours, an amount of time which is sufficient to allow all strains to exit lag-phase 
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and begin exponential growth, but not so long as to result in a large variation in cell 
densities among the strains (Figure 2.1).  
 
Figure 2.1: Growth rates of mutant strains in liquid culture 
Growth curves for a subset of 96 mutant deletion strains over a 600 minute time 
interval. Whereas the majority of the strains (A) grow at a rate which is similar to wild 
type, a small number of strains (B) grow at a slightly reduced rate, while one strain (C) 
grows very slowly. On the basis of these data, I chose to harvest cells after 4 hours of 
outgrowth, which ensures that the majority of the strains are harvested when A600~0.5.  
 
For the non-essential strains, all growth was conducted at 30°C. For the essential 
strains, the initial growth was done at 25°C (a permissive temperature for all strains), 
but the saturated cells were back-diluted into plates containing media pre-warmed to 
30°C (a non-permissive temperature for many, but not all, of the strains) and allowed 
to continue growing at 30°C for four hours. For both the non-essential and the 
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essential strains, two independent biological replicates were initiated from each 
saturated plate. After four hours of outgrowth, cells were harvested by centrifugation 
at 4000xg for five minutes. The cell pellets were flash frozen in liquid N2 and stored at 
-80°C until further processing. 
 
2.2.2 High-throughput RNA isolation 
Isolation of total cellular RNA was performed using custom protocols written for a 
Biomek NX liquid handling system. To each frozen cell pellet collected as described 
above, 50μl of Acid Phenol: Chloroform (5:1, pH<5.5) and 25μl of AES buffer 
(50mM sodium acetate (pH5.3), 10mM EDTA, 1% SDS) were added. The plates were 
sealed with plastic CapMats (Greiner BioOne, cat.#: 384070) and vortexed for five 
minutes at top speed on a plate vortex. The plates were incubated for 30 minutes in a 
water bath at 65°C with intermittent vortexing. After incubation, the plates were spun 
for one minute at 1000xg. An additional 35μl of AES buffer was added to each well, 
and after mixing the organic and aqueous phases were separated by centrifugation for 
five minutes at 3000xg. Using a slow aspiration speed, 40μl of the upper phase 
containing the RNA were robotically transferred to a new 384-well microtiter plate. 
The transferred aqueous phase was mixed with 3 volumes of RNA Binding Buffer 
(2M Guanidine-HCl, 75% isopropanol) and passed through a 384-well glass fiber 
column (Whatman, cat.#: 7700-1101) by centrifugation for two minutes at 2000xg. 
The column was washed twice with two volumes of Wash Buffer (80% ethanol, 
10mM Tris-HCl (pH8.0)), followed by a final dry spin for two minutes at 2000xg. To 
remove any contaminating genomic DNA, 5 µl of DNase Mix (1x DNase Buffer, 0.25 
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units of DNase I (Promega)) was added to each well and incubated at room 
temperature for 15 minutes. After the incubation, 80μl of RNA Binding Buffer was 
added to each well of the 384-well glass fiber plate and spun as before. After washing 
and drying as above, 15μl of sterile water was added to each well of the glass-fiber 
plate to elute the RNA into a clean 384-well microtiter plate (Greiner BioOne, cat. #: 
781280). In general, this procedure yielded about 1µg of total cellular RNA from each 
cell pellet. The quality of the RNA produced by this protocol is equal to our 
conventionally purified samples, and the effectiveness of the DNase treatment is 
demonstrated in Figure 2.2. 
 
Figure 2.2: Assessing Total RNA and cDNA quality 
A. A comparison of RNA quality between a “classic” phenol-extraction protocol and 
our robotic procedure. The diagram above the picture of the gel indicates the regions 
of a 384-well plate from which RNA was selected and run. Each lane contains about 
300ng of total cellular RNA and duplicates from each region of the plate are shown. 
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B. Effectiveness of the DNase treatment as measured by quantitative RT-PCR, 
demonstrating the shift in fluorescence before and after DNase treatment. The green 
text indicates the samples that were treated with DNase, whereas the black text 
indicates the untreated samples.  
C. The measured levels of Tef5 pre-mRNA in the indicated samples demonstrates that 
the contaminating genomic DNA is strongly depleted by DNase treatment. 
 
2.2.3 Synthesis of cDNA and quantitative PCR 
Total cellular RNA was converted into cDNA in 384-well microtiter plates. Of the 
15µl of RNA purified as described above, 10μl were used in a cDNA synthesis 
reaction that had a total volume of 20µl and which contained 50mM Tris-HCl (pH8.3), 
75mM KCl, 3mM MgCl2, 10mM DTT, 0.5mM each dNTP, 5µg dN9 primer, and 60ng 
M-MLV RT. Reactions were incubated overnight at 42°C. 
The cDNA reactions were diluted 30-fold with water, giving a final concentration of ~ 
1ng/µl based on the initial RNA concentration, and used without any further 
purification as templates in high-throughput quantitative PCR (QPCR) reactions. The 
QPCR reactions were performed in a reaction volume of 10µl, containing 5µl of 
template (~5ng of template), 10mM Tris-HCl (pH8.5), 50mM KCl, 1.5mM MgCl2, 
0.2mM each dNTP, 0.25x SYBR Green, 5% DMSO, 0.7ng Taq DNA polymerase, and 
250nM forward and reverse primers. The sequences of the primers used for each 
targeted RNA are shown in Table 2.1.  
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Table 2.1: Forward and Reverse primer sequences used for QPCR for each target 
RNA 
The list of forward and reverse primers used in this study. 
Target Forward primer Reverse primer 
U3 precursor 
(snR17a) 
TAT GTA ATA TAC CCC AAA CAT TTT 
ACC CAC 
AAA CTC TAG TAC CTA AGA CTT TTA 
GAT GCT 
Tef5 pre-mRNA 
GAT AGC ACA GAG CAG AGT ATC 
ATT A 
CTG GAG AAT TCT GGG TAA GCA GAT 
T 
Rpl31b pre-mRNA ATT TCT CTG TGT TCT GCG ATC GAT 
AGC GCC ATT ATA GTG TAA ACG TGA 
G 
Ubc13 pre-mRNA 
GAG CCG TCA CAC TCT ACA CTG TTT 
C 
TTG CGT TAG TAT GTA AGT TCT AGC 
CA 
Tub3 pre-mRNA 
GCA AAT AAT TTG ACT TGT ACC AGC 
A 
AGG TCA ATT ATG AGC TTT TTC GTC 
C 
Yra1 pre-mRNA 
ACA TTT TTA AGC TGG CGT ATT GTG 
T 
TAG GAA CTA ACT ATC ACG GTC GAG 
G 
Rec107 pre-mRNA 
TCG CTA AAC AAG TTT AAC CAG CTA 
CT AAA CTT GAG GGT ATG CAC TGT GTT 
U1 snRNA AAG TCC TAC TGA TCA AAC ATG CGC 
GGA GTT TGC ATC AAT GAC TTC AAT 
G 
Scr1 total 
CAG GAG GCG TGA GGA ATC CGT 
CTC T 
AAG GAC CCA GAA CTA CCT TGC CGC 
A 
Tef5 total 
CCA TTG TCA CTC TAG ATG TCA AGC 
C 
GAT ACC GAA ACC AAT TGG GAT 
AAA T 
Tub1 total 
AGA AAC TTG GAT ATC CCA AGA 
CCA A 
GCA ATT AGG TTG TTT AAG TTT GCA 
A 
Faa1 total TCT GCC CTA TGC TTA TTG GTT ACG 
TAA CAC AAC CTG TTA GGT CAC CAG 
C 
Srb2 total CGC GGA TGT CTC CAA GCT CA CGC GGA TGT CTC CAA GCT CA 
Mud1 total 
AAT AAG ACG CCT GAA GCA TAA 
GCT 
CTA TCA ATC TCA GCC TCC TCT ACC 
TT 
 
Standard curves were generated consisting of 4-fold serial dilutions of genomic DNA 
and covering a range of 1.6x10
5
 molecules. Each primer pair was well-behaved, 
showing an amplification efficiency of between 86% and 97% (Figure 2.3). Two 
technical replicates were measured for each biologically independent sample, 
generating four independent measurements for each of the ~5500 mutant strains.  
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Figure 2.3: Standard curves for quantitative PCR (QPCR) for all primer pairs 
Standard curves for all primer pairs used in this study. The Cp values (crossing points) 
are plotted against the logarithm of known starting sample amounts (in nanograms of 
genomic DNA). The equations that describe the curves as well as the R
2
 values are 
specified for each of the primer pairs 
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2.2.4 Processing QPCR data 
On the basis of standard curves generated using QPCR, relative nanogram quantities 
were calculated for every RNA transcript within each of the ~5500 strains tested. To 
assess reproducibility, coefficients of variation (CV) were determined for each primer 
pair and each strain. The vast majority of these were highly reproducible, both overall 
and on a per plate basis. As an initial quality filter, I chose to exclude any samples for 
which the CV was greater than 0.25.  
Because no simple mechanism exists to normalize for variability in each of the 
experimental steps, I instead chose to measure the levels of six different RNAs in each 
of the samples and use these to determine a composite normalization value to account 
for the overall yield in our procedure. The six RNAs were: U1 snRNA, Scr1 (SRP) 
RNA, Tef5 mRNA, Tub1 mRNA, Srb2 mRNA and Faa1 mRNA. These RNAs were 
chosen because their biological functions are diverse and their cellular levels vary over 
a broad range (~300-fold, Table 2.2).  
Table 2.2: Relative abundances of RNA species as measured by QPCR 
RNA species for which expression levels were measured and their corresponding 
levels. The values are normalized to the Tub3 pre-mRNA level, which was the lowest 
abundance transcript measured in our experiments. 
 
RNA Relative abundance 
U1 total 1800 
Scr1 total 1200 
Tef5 total 280 
Yra1 pre-mRNA 110 
U3 precursor 70 
Tub1 total 35 
Faa1 total 12 
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Srb2 total 5 
Rec107 pre-mRNA 3 
Rpl31b pre-mRNA 3 
Tef5 pre-mRNA 3 
Ubc13 pre-mRNA 2 
Tub3 pre-mRNA 1 
 
For both independent biological replicates of every strain, a composite normalization 
constant, 
ix
normC , was calculated according the following formula: 
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For each primer pair, 
ix
ng  represents the relative nanogram quantity calculated for an 
individual sample. Similarly, 
PlateMED
ng  represents the median value determined for a 
given primer pair on an individual QPCR plate run. Because of the subtle variations 
that are apparent from one plate run to the next, I found that this per plate 
normalization using 
PlateMED
ng  gave the most robust data. By determining the ratio of 
Plate
i
MED
x
ng
ng
 for every primer pair, a relative abundance of total RNA can be calculated 
for every sample. As seen in Figure 2.4, a histogram of 
ix
normC  values follows a 
normal distribution in log2 space with a variance of 1.5 units. A second filter at the 
level of 
ix
normC  values was introduced which allowed for the filtering of samples with 
very low amounts of cDNA.  
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Figure 2.4: Distribution of Cnorm values 
The distribution of the normalization constants (Cnorm) in log2 space for all samples in 
the biological replicate A dataset. The area highlighted in dark green comprises Cnorm 
values which have passed the Cnorm filter. All log2(Cnorm) values less than -3 (an 8-fold 
decrease from the median) were eliminated from the dataset. Above the histogram, a 
box and outlier plot underlines the same distribution of Cnorm values 
 
For strains that passed this filter, the normalized levels of a given RNA were 
determined according to the following formula: 
ix
ix
ix
norm
norm
ng
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The relative amount of RNA in a given strain was then determined according to the 
following formula: 
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For each primer pair, 
PlateMED
xnorm
ngRNA  represents the median value of the normalized 
RNA levels determined within a given QPCR plate. For each biological replicate of 
every strain, both the 
ix
ng and the 
ix
relRNA  values are available through Gene 
Expression Omnibus (GEO) using accession number GSE34330. 
 
2.2.5 Significance analysis of QPCR data 
To determine the subset of strains that cause a statistically significant increase or 
decrease in precursor levels, we employed the Significance Analysis of Microarrays, 
or SAM, program [37]. While this software was originally designed for the analysis of 
microarray data, a significance analysis of our QPCR data is subject to similar 
concerns regarding multiple hypothesis testing. For each RNA, SAM analysis was 
performed on the four 
ix
relRNA  values, comprised of both technical and biological 
replicates that were generated for each of the ~5500 strains. For each transcript, a one 
class SAM analysis was performed where the Δ value was adjusted to minimize the 
false discovery rate (FDR), yielding the following values: for the U3 precursor using 
Δ=0.983, FDR=0.045; for the Tub3 pre-mRNA using Δ=0.91, FDR=0; for the Rpl31b 
pre-mRNA using Δ=1.061, FDR=0.003; for the Ubc13 pre-mRNA using Δ=0.978, 
FDR=0.002; and for the Tef5 pre-mRNA using Δ=0.99, FDR=0.  
 
2.2.6 Splicing-sensitive microarrays 
The candidate non-essential deletion strains were grown to saturation in YPD at 30°C, 
then back diluted in 25ml cultures in flasks at a starting A600~0.2 and allowed to grow 
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at 30°C until they reached an optical density of between A600=0.5 and A600=0.7. The 
candidate essential strains were initially grown at 25°C in YPD, then shifted to the 
indicated temperatures for 15 minutes after they reached an optical density of between 
A600=0.5 and A600=0.7. In parallel with the collection of the mutant strains, wild type 
isogenic controls were grown and collected under the same conditions as the mutant 
strains examined. Total cellular RNA samples were isolated, converted into cDNA, 
and fluorescently labeled as previously described [31]. All microarrays were 
performed as two-color arrays comparing mutant and wild type strains, each grown 
under identical conditions. Both raw and processed microarray data are available 
through GEO using accession number GSE34330. 
 
2.2.7 Chromatin immunoprecipitation 
The U1C-Tap bdf1Δ and U1C-Tap bdf2Δ strains were generated by deleting the 
appropriate genes in the background of the U1C-Tap strain from Open Biosystems 
[57] using standard techniques. The strains were grown at 30°C in rich medium 
supplemented with 2% glucose (YPD) until they reached an optical density of 
A600~0.7. The chromatin was cross-linked with 1% formaldehyde for 2 minutes at 
30°C. Glycine was added at a final concentration of 125mM and the cultures were left 
shaking for another 5 minutes. Cell pellets from 50 ml of culture were collected by 
centrifugation at 1620xg for 3 minutes, then washed with 25ml ice-cold 1X PBS and 
the pellet stored at -80°C. The pellets were resuspended in 1ml Lysis buffer (50mM 
Hepes pH 7.5, 140mM NaCl, 1mM EDTA, 1% TritonX-100, 0.1% Na-deoxycholate 
supplemented with protease inhibitors) and lysed in the presence of 500µl 0.5mm 
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glass beads in a beat beater. The lysate was collected by centrifugation at 1000xg for 1 
minute, and then pre-cleared by spinning for 15 minutes at 14000rpm in a tabletop 
centrifuge at 4°C. The pellet was re-suspended in another 1ml of Lysis buffer and the 
chromatin was sheared to an average size of 300bp (range 100-500bp) by means of a 
Bioruptor sonicator. The sample was clarified by 2 cycles of centrifugation at 
14000rpm for 15 minutes in a tabletop centrifuge at 4°C and the resultant chromatin 
solution frozen and stored at -80C. From the chromatin samples a 1% Input sample 
was retained, and then each sample was split equally between a Mock IP and an IP 
sample. The IP samples were incubated with 5µl 0.5mg/ml anti-Tap Antibody 
(Thermo Scientific, CAB1001). After 2 hours at 4°C on a rotator, 25µl of protein A/G-
agarose resin (#Sc-2003Santa Cruz) was added to all samples and they were further 
incubated for another 2h at 4°C. The resin was washed twice with 1ml Lysis buffer, 
twice with 1ml Wash buffer (10mM Tris-HCl, 25mM LiCl, 0.5% NP-40, 0.5%Na-
deoxycholate, 1mM EDTA) supplemented with 360mM NaCl, twice with 1ml Wash 
buffer, and finally twice with 1ml TE. The first wash was a brief one, followed by a 15 
minute incubation of the samples on a rotator at 4°C for the second wash. In between 
washes, the resin was collected by short spins at 2000rpm in a tabletop centrifuge. The 
resin was resuspended in 100ul Elution buffer (50mM Tris-HCl pH8.0, 5mM EDTA, 
1% SDS) and the immunoprecipitated material was eluted from the beads by 
incubating at 65°C for 30 minutes with occasional tapping. To reverse crosslinks, the 
IPs and the 1% Input samples were incubated overnight in a 65°C water bath. The next 
day, the samples were treated with 12.5µl 20mg/ml Proteinase K solution and 
incubated at 42° for 2h. The DNA was then purified by using a Cycle Pure Kit 
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(Omega Bio-Tek, D6492-01) following the manufacturer’s instructions and eluted in a 
final volume of 120µl.  
Quantitative real-time PCR was performed on a Roche Light Cycler 480 machine as 
described above, using the 1% Input sample to generate a standard curve for each of 
the primer pairs we used. For the primers used in the screen, the sequences are 
available in Table 2.1.  The primers for the different regions of actin gene and the 
PMA1 gene are the same as previously published [5]. For each sample the Mock IP 
value calculated as percent input was subtracted from the IP value (in percent input). 
Then, a fold enrichment value was calculated, by dividing these values by the PMA1 
value. 
 
2.2.8 Mud1 overexpression 
An overexpressing plasmid containing a full-length copy of the Mud1 gene including 
~500bp up- and down-stream of the ORF was transformed into BY4741 (Open 
Biosystems). This strain and a control strain containing the empty vector were grown 
in 25 ml minimal media until they reached an optical density of A600~0.5-0.6. RNA 
isolation was performed as previously described [31], and cDNA synthesis and Q-
PCR were performed as described above. The primer sequences are found in Table 
2.1. 
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2.3 Results 
 
2.3.1 A high-throughput method for measuring cellular levels of specific RNA 
species 
 
To identify the comprehensive network of cellular factors that lead to a change in 
splicing efficiency, I developed a high-throughput reverse genetic screen that allowed 
me to readily assess changes in pre-mRNA levels in the background of ~5500 
Saccharomyces cerevisiae strains, each of which contained a mutation in a single 
gene. The library of strains contained deletions of non-essential genes [24] as well as 
conditional mutations in essential genes [25], accounting for mutational access to over 
93% of known yeast genes. Using a liquid-handling robot, protocols were developed 
(see Materials and Methods) that allowed for the simultaneous collection of each of 
these strains under exponential growth conditions in liquid medium in 384-well plates. 
Total cellular RNA was isolated robotically from each of these strains using a phenol 
extraction protocol [23] followed by a glass-fiber purification step [26]. After 
converting this RNA into cDNA using a random-priming strategy, QPCR was used to 
directly measure the level of a given RNA species within each strain. Because of the 
inherent variability between the samples in the cell collection, RNA isolation, and 
cDNA synthesis steps, the levels of six different RNA species were measured in each 
of the samples in order to calculate a normalization constant. On the basis of this 
normalization constant, the relative level of virtually any cellular RNA species can be 
determined in each of the mutant strains. 
As an initial test of the approach I sought to identify the full complement of factors 
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involved in pre-mRNA splicing by determining the relative levels of unspliced U3 
small nucleolar RNA (snoRNA) present in each of the mutant strains. The U3 
snoRNA is unique in the S. cerevisiae genome in that it is the only known non-coding 
RNA that is interrupted by a spliceosomal intron [27]. Nevertheless, the U3 transcript 
has been widely used historically as a splicing reporter, owing to its relatively high 
basal expression level and the strong accumulation of U3 precursor levels observed in 
the background of canonical splicing mutants [13,28,29]. As shown in Figure 2.5, the 
U3 precursor levels are unaffected in the vast majority of the strains examined, with 
levels varying by less than 1.35-fold from one another for 95% of the strains.  
 
Figure 2.5: A subset of gene disruptions causes an increase in the unspliced levels 
of U3 snoRNA 
A. The relative level of U3 snoRNA precursor in 5122 strains, ordered from the 
highest to lowest. Red data points highlight the strains containing mutations in a factor 
within the GO PROCESS: RNA Splicing category (see also Figure 2.6). To the right, a 
box and outlier plot for the same dataset. 
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B. False color representation of both the A (left) and B (right) biological replicates. 
The values are ordered from high to low, mirroring the data in (A). 
 
Indeed, only ~200 of the ~5100 strains that passed the quality filters (see Materials 
and Methods) showed a change in the relative U3 precursor levels of more than ~30% 
from the median value (~0.35 in log2-transformed space), consistent with the 
expectation that mutations in most genes will have little or no effect on cellular pre-
mRNA splicing efficiency. The tight distribution of relative U3 precursor levels seen 
within this dataset demonstrates the high precision with which these measurements 
can be made, and suggests a low false discovery rate for this approach.  
 
2.3.2 Known spliceosomal components dominate the top subset of mutations 
To characterize the data generated by this approach I sought to define the biological 
significance of those strains that showed increased levels of U3 precursor. As an initial 
analysis, I examined the U3 precursor levels in those strains containing mutations in 
known splicing genes. Using the GO PROCESS: RNA Splicing as a guide [30], a total 
of 71 strains in our library were classified as containing mutations in canonical 
splicing factors (Figure 2.6), of which 68 passed our quality filters for the U3 
precursor dataset (see Materials and Methods).  
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Figure 2.6: Splicing factors included within strain library 
Within the “GO process: RNA splicing” box are listed all splicing factors as annotated 
by Gene Ontology [30]. These factors have been subdivided based on the presence or 
absence of a strain within the library, and further by the presence or absence of data 
from the final filtered dataset. The subset highlighted in red represents the strains 
which passed all the filters in the U3 snoRNA precursor screen. Strains for which 
there is “NO DATA” that passed the quality filters are listed separately. Factors for 
which “NO STRAIN” was present in the library are also noted. I “MANUALLY 
REMOVED” several strains that are included by Gene Ontology but that I felt are 
either are not part of the spliceosome or have a yet uncharacterized function. In 
addition, I have “MANUALLY ADDED” three factors which are known to impact 
splicing. Two more strains that partially “DISRUPT READING FRAMES” of specific 
splicing factors (indicated in the parentheses) were also added to the dataset. 
 
A strong overrepresentation of these splicing factors can be seen within the set of 
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strains showing an enrichment of U3 precursor (Figure 2.5A). Of the 68 strains 
containing splicing mutations that passed the quality filters: 53 are found within the 
top 200 strains (p=9.28E-64, Fisher's exact test); 38 are found in the top 50 strains 
(p=1.33E-66); and the top 14 strains all belong to this list (p=1.27E-27). Taken 
together, these data argue strongly that the candidates identified by this approach will 
be characterized by a high true positive discovery rate. 
By contrast, out of the 68 strains containing mutations in known splicing factors for 
which I obtained high quality data, 15 failed to show an enrichment of U3 precursor 
levels in this dataset, suggesting either that mutations in these genes don’t cause an 
increase in U3 precursor levels (true negative), or that our approach incorrectly failed 
to detect the accumulation of unspliced U3 (false negative). To better resolve these 
possibilities I chose to more completely examine the global splicing fitness of some of 
these strains using splicing-sensitive microarrays. For every intron-containing gene in 
the genome, these custom-designed microarrays contain at least three probes (Figure 
2.7A) that allow us to distinguish between spliced and unspliced isoforms [31]. I used 
these microarrays to assess the global splicing defects of four mutants: two canonical 
splicing mutants that showed strong U3 precursor accumulation (snt309Δ and lsm6Δ, 
Figure 2B), and two that showed little or no accumulation (mud2Δ and cus2Δ, Figure 
2.7C).  
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Figure 2.7: Not all mutations in splicing factors result in defective splicing for all 
intron-containing genes 
A. Splicing-sensitive microarrays contain probes that target precursor (P), mature (M), 
and total (T) mRNA levels. 
B. Global splicing profiles of the snt309Δ and lsm6Δ strains, showing a strong splicing 
defect for both mutants.  
C. Global splicing profiles of the mud2Δ and cus2Δ strains, illustrating different 
splicing defects for these mutants. Whereas many transcripts show a splicing defect in 
the mud2Δ strain, many continue to be efficiently spliced. Similarly, most intron-
containing genes show no splicing defect in the cus2Δ strain. 
D. The behavior of specific transcripts in the different mutant backgrounds.  
E. Locations within the U3 precursor dataset of the mutant strains for which 
microarrays are shown in (B) and (C). 
As expected, and consistent with previous work from others [32], the snt309Δ and 
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lsm6Δ strains demonstrate a broad splicing defect, with most intron-containing genes 
displaying an increase in precursor levels accompanied by a decrease in the amount of 
spliced mRNA. By contrast, the global splicing profiles of the mud2Δ and cus2Δ 
strains are markedly different. In the cus2Δ background, few intron-containing genes 
display a splicing defect: very little precursor accumulation is observed, and there is 
little if any detectable loss in mature mRNA. The mud2Δ mutation does cause a 
splicing defect for some intron-containing genes, whereas little change in splicing 
efficiency is seen for many others. Notably, as seen in Figure 2.7D, the microarrays of 
both the snt309Δ and lsm6Δ strains show a strong accumulation of U3 precursor 
levels, whereas the mud2Δ and cus2Δ strains show almost no accumulation, consistent 
with the QPCR screen results. It is worth noting that in my experience the behavior of 
the U3 transcript differs from the other intron-containing genes in that every splicing 
mutation I have examined that causes an increase in the U3 precursor levels also 
results in an increase in the total level of U3; the reason for this apparent discrepancy 
is currently under investigation. Nevertheless, these microarray data demonstrate that 
the failure to detect an increase in U3 precursor levels in the mud2Δ and cus2Δ strains 
does not represent a failure of the approach, but rather that these are true negative 
results. 
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2.3.3 Assessing transcript-specificity of the mutants 
To better assess the total complement of genes that can impact the splicing of any 
precursor transcript, I chose to expand the analysis by measuring the precursor levels 
of several additional intron-containing genes. I chose to examine four ‘canonical’ 
intron-containing genes (RPL31B, UBC13, TUB3 and TEF5) that vary in terms of 
intron size, transcriptional frequency, biological function, and the presence or absence 
of an intron-encoded snoRNA. In spite of these differences, these transcripts are 
similar to one another in so much as they each contain splice site and branch point 
sequences that conform to consensus sequences. In addition to these four genes, I 
chose to examine two intron-containing genes (YRA1 and REC107/MER2) that are 
known to be poorly spliced under standard growth conditions [21, 33, 34]; as such, I 
expected the behavior of these two transcripts to be distinct from the efficiently 
spliced transcripts. For all six of these genes, the precursor levels were measured in all 
~5500 strains. As an initial analysis of this data set, I considered the behavior of the 71 
strains containing mutations in spliceosomal components (Figure 2.8).  
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Figure 2.8: Mutations in most known splicing factors lead to increased precursor 
levels of canonical splicing substrates 
Relative levels of the indicated RNAs are shown in the background of all strains 
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containing mutations in known splicing factors. The biological replicates (A and B) 
are shown for each RNA. Precursor levels for all transcripts are ordered based on the 
average expression values of U3 precursor, from high to low values. Gene disruptions 
are indicated on the left (-ts indicates a temperature sensitive allele). Insets to right 
indicate the location of the data in the U3 precursor dataset. 
A. Mutations that lead to an increase in the U3 snoRNA. 
B. Mutations that do not affect U3 precursor levels but may affect the levels of other 
intron containing genes. 
C. The increase of Rec107 precursor levels seen in the ufp1Δ and upf2Δ backgrounds, 
and the increase of Yra1 precursor levels seen in the edc3Δ background are consistent 
with their well-characterized degradation pathways. 
 
As expected, precursor accumulation can be detected for each of the canonical intron-
containing transcripts in the background of nearly all of the splicing mutations. While 
all four canonical precursors accumulate in the mud2Δ background, consistent with the 
microarray data, no precursor accumulation is detected for any of these transcripts in 
the cus2Δ strain (Figure 2.8B). In addition, several of the splicing mutants that failed 
to cause an increase in the U3 precursor levels do cause a splicing defect for these 
other transcripts. Importantly, the behavior of the Rec107 and Yra1 pre-mRNAs 
within this subset of strains differs significantly from that seen for the canonically 
spliced transcripts. Splicing of the Rec107 pre-mRNA shows a strong accumulation in 
the upf1Δ and upf2Δ strains (Figure 2.8C), consistent with its known degradation via 
the nonsense-mediated decay pathway [35]. Because the Rec107 pre-mRNA does not 
engage the spliceosome during vegetative growth [21], no precursor accumulation is 
expected in strains containing spliceosomal mutations. Likewise, the Yra1 pre-mRNA 
shows a strong accumulation in the edc3Δ strain [34], consistent with its previously 
characterized cytoplasmic degradation pathway. The failure to detect Yra1 pre-mRNA 
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accumulation in strains containing spliceosomal mutations presumably reflects the 
inherently high levels of unspliced Yra1 transcript present in a wild type cell. Taken 
together, these data strongly support the capacity of this approach to successfully 
identify mutations that impact pre-mRNA splicing with low false positive and false 
negative rates of discovery. 
 
2.3.4 Global splicing efficiency is impacted by many cellular mutations 
To expand this analysis beyond previously characterized splicing factors, I sought to 
identify novel mutations that caused an increase in precursor levels in most, if not all, 
of the canonical intron-containing genes I analyzed. By determining the rank order of 
precursor accumulation in each strain for each of the five canonical splicing substrates 
(U3, Rpl31b, Tef5, Tub3, and Ubc13 precursors), a composite rank order of each 
strain was calculated as the average of these independent measurements (Figure 2.9).  
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Figure 2.9: Increases in precursor levels correlate with a decrease in splicing 
efficiency 
A. Relative levels of the indicated RNAs are shown in the background of 5334 strains. 
The data are ordered from high to low values based on a composite rank order, 
determined on the basis of the expression levels of the five canonical splicing 
substrates.  
B. The relative splicing efficiency of the Tef5 transcript in each of these strains, 
calculated as the relative Tef5 precursor levels divided by the relative Tef5 total RNA 
levels.  
C. The relative levels of the low abundance Rec107 pre-mRNA and Faa1 transcripts 
are shown along with the inefficiently spliced Yra1 pre-mRNA, none of which shows 
a similar pattern to the splicing defects seen in (A). 
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Remarkably, while the majority of the mutations examined cause little or no change in 
precursor levels of these four transcripts, the subset of mutations which do cause 
detectable increases in precursor levels is larger for some of the coding mRNAs than 
was seen for U3. Interestingly, although there is variation in the number of strains that 
cause pre-mRNA accumulation of the different transcripts, with 
Tub3<Tef5<Ubc13~Rpl31b, strong overlap can nevertheless be identified across the 
four transcripts. For example, the majority of the strains that cause an increase in the 
Tub3 pre-mRNA also display an increase in the pre-mRNA levels of the other three 
transcripts. By contrast, many strains cause a strong accumulation of the Ubc13 and 
Rpl31b pre-mRNAs without causing a significant change in the Tub3 or Tef5 pre-
mRNA levels.  
Because the absolute levels of the Rpl31b, Tef5, Tub3 and Ubc13 pre-mRNAs are 
significantly lower than the U3 precursor levels in most strain backgrounds (Table 
2.3), I considered the possibility that these results reflected a technical artifact 
associated with measuring the cellular levels of low abundance RNA species in certain 
strain backgrounds. Importantly, however, the relative levels of the Rec107 pre-
mRNA, whose normal cellular level is similar to these other pre-mRNAs, is largely 
unchanged in the vast majority of the strains examined (Figure 2.9). Likewise, an 
analysis of the cellular levels of the Faa1 mRNA, an intronless gene whose transcript 
abundance is of a similar magnitude as the Rpl31b, Tef5, Tub3 and Ubc13 pre-
mRNAs, also shows a nearly constant level in all of the examined strains, further 
suggesting that there is no inherent bias in detecting low level transcripts. Finally, the 
Yra1 pre-mRNA, which is inefficiently spliced and has a higher endogenous level than 
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most pre-mRNAs, also shows very little change in the examined strains. Taken 
together, these results strongly support the conclusion that the levels of the Rpl31b, 
Tef5, Tub3 and Ubc13 pre-mRNAs are increased in these strains. 
 
2.3.5 Increases in precursor levels correlate with a decrease in splicing 
efficiency 
Because this approach, as described so far, directly measures the cellular levels of 
precursor RNA but does not directly determine the efficiency of splicing per se, those 
mutations which cause an increase in the precursor levels could be doing so simply by 
increasing the transcriptional frequency of these genes rather than by directly 
impacting their splicing. To distinguish this possibility from a true splicing defect, I 
chose to directly calculate the splicing efficiency of the Tef5 transcript by measuring 
the total cellular level of Tef5 mRNA by QPCR in each strain and using this value to 
calculate the ratio of unspliced:spliced RNA in the cell, a classical measure of splicing 
efficiency. Consistent with a splicing rather than transcriptional cause for precursor 
accumulation, the measured levels of total Tef5 transcript showed little variation 
across nearly the entire set of strains (Figure 2.10). Indeed, nearly every strain that 
showed an increase in Tef5 pre-mRNA levels also showed a decrease in the splicing 
efficiency of the Tef5 transcript (Figure 2.9), suggesting that those mutations affect 
the splicing of this transcript rather than its transcription. These results strongly 
suggest that the increased pre-mRNA levels observed in these strains largely reflect 
changes in pre-mRNA splicing. 
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Figure 2.10: Global changes in Tef5 RNA levels 
A. Total RNA levels of the Tef5 transcript in 5198 strains which passed the quality 
filters. The total RNA levels are presented in log2 space as a composite behavior of 
both biological replicates, and are ordered from the highest (left) to the lowest (right) 
values. On the right side of the figure the data are presented as a heat map, with both 
biological datasets (A and B) shown. The data in the heat map are ordered from the 
highest to the lowest values, similar to the representation on the left.  
B. A comparison of the levels of Tef5 pre-mRNA versus the splicing efficiency of this 
transcript (calculated as a ratio of precursor Tef5 to total Tef5 levels across the entire 
dataset) shows a strong correlation. 
C. A comparison of the relative growth rate of the non-essential library strains [36] 
versus the Tef5 pre-mRNA levels reveals no correlation between cellular fitness and 
splicing efficiency. 
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To assess the functional significance of the strains displaying increased pre-mRNA 
levels, I sought to rule out the possibility that mutations which cause a change in 
overall cellular fitness might indirectly lead to a decrease in overall splicing 
efficiency. To test this, I compared our precursor accumulation levels with recently 
described strain fitness data calculated for each of the 5000 non-essential genes [36]. 
This comparison yielded no correlation between precursor accumulation and cellular 
fitness (Figure 2.10C), suggesting that cellular growth rate alone is insufficient to 
explain the observed increase in pre-mRNA levels. 
 
2.3.6 Assessing the statistical significance of the precursor accumulation 
While the precursor accumulation seen for each of the canonical transcripts in the 
known splicing mutants lends strong empirical support for the overall robustness of 
this approach, additional analysis was needed to assess the statistical significance of 
the data. Towards this end, I employed a statistical approach originally developed for 
analysis of microarray data called Significance Analysis of Microarrays [37], or SAM 
(see also Materials and Methods). I chose this software because, conceptually, the data 
generated by the QPCR approach are orthogonal to those from a microarray 
experiment: whereas a microarray experiment examines the behavior of thousands of 
mRNAs in a single strain, here it examines the behavior of a single RNA in thousands 
of different strains. Because similar concerns regarding multiple hypothesis testing 
apply to both types of data [38], I used this software as a tool for assessing the quality 
of the data. The results of the SAM analysis were consistent with the qualitative 
results seen in Figure 2.9, in so much as the number of strains causing a statistically 
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significant increase in the levels of each precursor species varied depending upon the 
precursor mRNA in question. A total of 224 strains caused a statistically significant 
increase in the Rpl31b pre-mRNA levels, 209 strains caused a significant increase in 
Ubc13 pre-mRNA levels, 146 strains caused a significant increase in U3 precursor 
levels, 83 strains caused a significant increase in Tef5 pre-mRNA levels, and 78 
strains caused a significant increase in Tub3 pre-mRNA levels. Importantly, many of 
the SAM-identified strains are found to cause a significant enrichment of the precursor 
levels of all five of these RNAs, including the majority of strains with mutations in 
canonical splicing factors. 
Interestingly, for some of the species examined, a small number of strains were 
identified which showed decreased levels of precursor RNA. In certain instances these 
reflected expected outcomes: a large decrease in the Ubc13 precursor was identified in 
the ubc13Δ strain, for example. However, in other cases these may indicate important 
biological phenomena. For example, both the xrn1Δ and the tfg2Δ strains cause a 
significant decrease in the U3 precursor levels. It has been previously shown that 
deletion of the Xrn1 nuclease paradoxically leads to decreases in many precursor 
RNAs [39], although the mechanism by which this occurs remains unknown. 
Likewise, it is unclear whether the decreased precursor resulting from deletion of the 
TFIIF component Tfg2 reflects an overall decrease in transcription of this gene, or 
whether this in fact reflects increased splicing efficiency perhaps resulting from a 
decreased transcription elongation rate [10]. 
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2.3.7 Top screen candidates predict specific links between splicing and several 
pre-mRNA processing pathways. 
To better characterize the factors that impact pre-mRNA splicing, we examined the 
lists of SAM-identified candidates for factors that are not canonical components of the 
spliceosome. As an initial approach, I asked whether any functional categories of 
proteins were statistically overrepresented within this set of strains. For this analysis, I 
ordered the strains according to the largest precursor accumulation that they affected 
for any of the RNA species. I then used the GO::Term Finder program [40] to identify 
overrepresented classes of genes. As expected, when considering the 50 strains that 
caused the largest precursor accumulations, a strong enrichment for splicing factors 
was seen with 30 out of 50 strains containing mutations in genes belonging to the GO 
PROCESS: RNA Splicing category (p=1.3E-40 with Bonferroni correction). 
Interestingly, when the top 100 strains are considered, significant enrichment can also 
be seen for strains with mutations in factors belonging to the GO PROCESS: 
Chromatin Remodeling category, with eight different mutants causing precursor 
accumulation (arp5Δ, arp8Δ, bdf1Δ, npl6Δ, rsc2Δ, rsc9-ts, vps72Δ, and yaf9Δ; 
p=1.5E-03). Expanding the analysis to the top 200 candidates increases the enrichment 
of this category to include twelve factors (adding arp6Δ, swc5Δ, swr1Δ, and taf14Δ; 
p=1.8E-04). Interestingly, within the top 200 candidates, significant enrichment is also 
seen for the GO PROCESS: RNA Catabolic Process category, with 13 different 
factors being present (ccr4Δ, dis3-ts, dbr1Δ, kem1Δ, lsm2-ts, lsm6Δ, lsm7Δ, prp18Δ, 
rrp6Δ, rtt101Δ, ski3Δ, ssn2Δ, and upf3Δ; p=8.5E-03). Whereas some of these factors, 
such as lsm2-ts, lsm6Δ, lsm7Δ, and prp18Δ are known to directly function in pre-
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mRNA splicing, the identification of many of these factors presumably reflects their 
defects in degradation pathways for unspliced pre-mRNAs. 
One of the top factors I identified that bridges chromatin remodeling with transcription 
initiation is the bromodomain factor Bdf1. Bdf1 is a member of the SWR1 complex 
and, along with its homolog Bdf2, has been shown to interact with the TFIID 
component of RNA polymerase II [41]. Moreover, BDF1 and BDF2 have been 
demonstrated to be genetically redundant with one another. Whereas the SAM 
analysis indicated that the bdf1Δ caused a statistically significant accumulation of 
most of the canonical precursor species in our experiments, the bdf2Δ strain showed 
little or no detectable increase in the levels of any of the precursors tested (Figure 
2.11), and was not considered by SAM analysis to be significant for increases in any 
of the precursor RNAs. To better characterize the global splicing profile of these two 
mutants, we again turned to splicing-sensitive microarrays. Remarkably, a dramatic 
splicing defect can be seen in the bdf1Δ strain for most intron-containing genes, as 
evidenced by an increase in the precursor transcript levels with a concomitant decrease 
in the mature and total transcript levels (Figure 2.11A). By comparison, the bdf2Δ 
mutation has almost no effect on cellular splicing, strongly corroborating the specific 
identification of Bdf1 in our screen. 
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Figure 2.11: Mutations in chromatin remodeling factors can impact splicing in a 
global or transcript-specific manner 
Splicing sensitive microarrays of candidate factors (A) bdf1Δ and bdf2Δ, (B) vps72Δ, 
and (C) rsc9-ts, as compared to the phenotypes of known splicing mutants snt309Δ 
and lsm6Δ. For each panel, the asterisk indicates the strain by which the data have 
been organized using hierarchical clustering, with the other data sets in those panels 
sharing an identical gene ordering. The orange bar highlights the location of specific 
subsets of transcripts showing splicing defects. The bottom insets show the location of 
each of the candidates within the U3 precursor dataset. Also, the locations of each of 
the components of the SWR complex are shown in blue, and each of the components 
of the RSC complex are shown in green. 
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To better assess the mechanism by which Bdf1 impacts pre-mRNA splicing, we 
monitored U1 snRNP recruitment in the background of wild-type, bdf1Δ, and bdf2Δ 
strains using chromatin immunoprecipitation coupled to QPCR (ChIP-QPCR). As 
seen in Figure 2.12, these experiments show that the deletion of Bdf1 but not of Bdf2 
decreases the occupancy of U1snRNP at several intron-containing genes, suggesting 
impairment of co-transcriptional spliceosomal recruitment in the bdf1Δ strain. A more 
comprehensive ChIP-Seq experiment will be required to fully characterize the global 
landscape of genes impacted by the deletion of Bdf1 and further characterize the roles 
of Bdf1 and Bdf2 in transcription and splicing. 
 
Figure 2.12: U1 snRNP recruitment is diminished upon Bdf1 deletion  
Chromatin immunoprecipitation (ChIP) was performed using a Tap tagged version of 
Yhc1 (U1C) in wild type, bdf1Δ, and bdf2Δ strains to assess the co-transcriptional 
occupancy of the U1 snRNP. A) Primers that had been previously used in a similar 
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assay [5] allowed us to monitor by quantitative PCR the amount of U1 snRNP 
associated with different genomic regions of the ACT1 gene. The plotted values were 
calculated as the percent of input signal detected at given region within the actin gene 
divided by the percent of input signal observed for the intronless gene PMA1. The 
error bars represent the standard deviations of technical replicates. B) The ChIP 
samples described above were assayed with the same primers used in our screening 
which targeted intronic regions of the U3 snoRNA, Rpl31B and Ubc13 pre-mRNAs. 
As above, the values are presented as fold enrichment over the intronless gene PMA1 
and the error bars are indicate standard deviation of technical replicates. For all four 
intron-containing genes, decreased levels of U1 snRNP are detected in the bdf1Δ strain 
relative to both the wild type and bdf2Δ strains. 
 
I also chose to further examine several factors that were identified in the screen that 
are more classically connected with chromatin remodeling. The lower panels of Figure 
2.11B and 2.11C show the locations within the U3 precursor dataset of all of the 
strains containing mutations in components of the SWR1 complex and the RSC 
complex respectively. Notably, mutations in many but not all of the components of 
these complexes cause a splicing defect of the U3 transcript. Moreover, each of the 
five precursor species that I examined shows a slightly different susceptibility to the 
different components of these complexes. I chose to examine the global splicing 
defects of strains containing mutations in two of these components: Vps72, a member 
of the SWR1 complex; and Rsc9, a member of the RSC complex. Splicing-sensitive 
microarrays of the vps72Δ and rsc9-ts strains, respectively, reveal a splicing defect in 
each strain (Figures 2.11B and 2.11C). However, unlike the bdf1Δ strain, the vps72Δ 
and rsc9-ts strains cause a splicing defect in only distinct subsets of intron-containing 
genes. Interestingly, the affected subsets of transcripts are neither completely 
overlapping nor completely independent of one another; rather the microarray data are 
consistent with the QPCR data in suggesting that mutations in specific chromatin-
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modifying components can result in aberrant splicing of specific pre-mRNA 
transcripts. 
While an ontology-based approach can successfully identify entire pathways that 
display enrichment, I was also interested in considering those factors which showed 
strong pre-mRNA accumulation but whose functional categories were not statistically 
over-represented at the top of our dataset. Remarkably, while the GO PROCESS: RNA 
3’ end Processing wasn’t significantly overrepresented as a category within our 
dataset (9 out of top 200, p=0.09), several strains with mutations in factors belonging 
to this category resulted in a strong, statistically-significant accumulation of multiple 
precursor species. Included among these were: yth1-ts, a zinc-finger containing protein 
that is the homolog of human CPSF-30; cft2-ts, the homolog of human CPSF-100; and 
fip1-ts, a component of the polyadenylation factor PF I. To further examine the global 
splicing defects of each of these mutants, microarrays were performed comparing 
mutant and wild type behavior after shifting them to both elevated and reduced 
temperatures. Of the three mutants, the profile seen in the yth1-ts mutation most 
closely resembles a canonical splicing defect, with more than half of the genes 
showing an increase of precursor and loss of mature RNA (Figure 2.13A).  
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Figure 2.13: Mutations in 3’ end processing mutants result in transcript-specific 
splicing defects 
Splicing sensitive microarrays for the cleavage and polyadenylation factor mutants 
yth1-ts (A), cft2-ts (B), and fip1-ts (C). For each panel, the data have been 
independently organized using hierarchical clustering. The orange bar highlights the 
location of specific subsets of transcripts showing splicing defects. 
 
Interestingly, the splicing defect is strongest at reduced temperatures even though this 
strain has only a subtle low-temperature growth defect (Figure 2.14).  
 67 
 
Figure 2.14: Growth phenotypes for 3'end mutants 
Serial four-fold dilutions of temperature sensitive alleles at various temperatures. The 
brr5-1 allele exhibits the well known cold-sensitive phenotype, as well as a growth 
defect at 37°C.The temperature sensitive alleles yth1-ts, cft2-ts and fip1-ts all show 
growth defects at 37°C, while displaying slower growth at 30°C. The most 
pronounced growth defect at 30°C as well as at the permissive temperature is seen for 
yth1-ts.  
 
By comparison, neither the cft2-ts nor the fip1-ts strains showed a strong splicing 
defect at low temperature (not shown), but each mutant was characterized by an 
unusual phenotype at elevated temperatures. As seen in Figures 2.13B and 2.13C, two 
distinct types of behavior are seen in the cft2-ts and fip1-ts mutants, respectively, that 
are largely defined by whether or not the affected transcript encodes a ribosomal 
protein gene (RPG). For a subset of the non-RPG transcripts a canonical splicing 
defect is apparent, consistent with our QPCR results. Interestingly, the subset of 
affected non-RPG transcripts is different between the two mutant strains. By 
comparison, nearly all of the RPG transcripts show a dramatic increase in both the 
mature and total mRNA levels, with little or no detectable change in precursor levels. 
The strong increases caused by these mutants suggest that the RPG transcripts may be 
subject to regulatory control at their 3’ ends. Interestingly, while it has long been 
known that RPG introns are, in general, longer than non-RPG introns [42], whereas 
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the second exons of RPGs tend to be shorter than non-RPGs [5], I nevertheless find no 
strong correlation between either intron or second exon length and the strength of the 
splicing defect seen for these 3’ end mutants (data not shown). The mechanisms by 
which these 3’ end factors impact pre-mRNA splicing are currently under 
investigation. 
 
2.3.8 Top screen candidates do not cause changes in the cellular mRNA levels of 
most spliceosomal components 
In considering the mechanisms by which candidate factors may be functioning, I 
sought to determine whether any of the candidates we examined might be indirectly 
affecting pre-mRNA splicing by changing the cellular levels of known spliceosomal 
components. Although the splicing-sensitive microarrays were designed primarily to 
interrogate the splicing status of the ~300 intron-containing genes in S. cerevisiae, 
they also contain probes against all ~6000 protein-coding genes and ~200 RNA genes, 
including the spliceosomal snRNAs. Figure 2.15 shows the relative RNA levels for 
each of the canonical spliceosomal components, including the snRNAs, in the 
background of each of the different strains we examined, as determined from our 
microarray analyses. While these results positively recapitulate the expected changes 
(for example, the decreases in Snt309 and Lsm6 mRNA levels in the snt309Δ and 
lsm6Δ strains, respectively), with only a few exceptions, most spliceosomal 
components appear unchanged in most of the mutants we examined.  
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Figure 2.15: The RNA levels of most spliceosomal factors are unchanged in most 
mutants 
Total RNA levels for all splicing factors in the background of different gene deletions 
or point mutations for which microarrays were performed. The data are organized on 
the basis of the highest to the lowest average change in the snt309Δ and lsm6Δ strains. 
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Importantly, the transcript encoding the Mud1 protein showed dramatic mis-regulation 
in both the yth1-ts and cft2-ts strains, increasing by more than 10-fold in each 
background. To test whether Mud1 overexpression might be causing the splicing 
defects observed in these strains, a strain was constructed where the wild type Mud1 
transcript was encoded on a high-copy plasmid. As seen in Figure 2.16, in spite of the 
over 30-fold increase in Mud1 levels in this strain, there is no detectable change in 
pre-mRNA splicing. Therefore, while the mis-regulation of Mud1 levels in these 3’ 
end mutants suggests that, similar to its human homolog, Mud1 levels in yeast may be 
subject to negative regulation via its 3’ end processing [43], it nevertheless appears 
that the splicing defect observed in these strains is not a consequence of Mud1 
overexpression. 
 
Figure 2.16: Mud 1 overexpression does not cause increases in precursor levels 
A high copy plasmid (2-micron) containing the Mud1 gene was transformed into an 
otherwise wild type strain in order to affect its overexpression. The expression levels 
of Mud1 and several precursor RNAs were monitored by quantitative real-time PCR 
and compared to a wild type strain containing an empty vector. The data were 
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normalized to the expression of the intronless Faa1 transcript to account for loading 
differences in the samples. While a >30-fold increase is apparent for the Mud1 
transcript, no increase is detected in the precursor levels of any of the RNAs surveyed, 
suggesting that their splicing is unaffected by Mud1 overexpression. The error bars 
represent the standard deviation of technical replicates. 
 
Interestingly, several of the strains, including bdf1Δ, yth1-ts, cft2-ts, and fip1-ts, 
showed an ~2-fold increase in the levels of both the U1 and U2 snRNAs. Although 
spliceosomes function as an equimolar complex of all five snRNAs, the total cellular 
levels of the snRNAs vary: in yeast, the U2 snRNA is the most abundant [44], while in 
mammals the U1 snRNA is most abundant [45]. While recent work demonstrates the 
cellular defects associated with decreased levels of snRNA [46], it is less clear 
whether increases in their levels will impart a defect on global splicing. Nevertheless, 
because each of these strains shows a similar increase in these snRNA levels but 
distinct splicing defects, it seems unlikely that the changes in snRNA levels alone can 
explain the observed splicing phenotypes. However, it is not inconceivable that small 
changes in levels for one or more of these transcripts could lead to the observed 
splicing defects. As such, additional work will be necessary to determine the 
functional consequences of these mutations. 
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2.4 Discussion 
2.4.1 A high-throughput, reverse genetic approach to measure the cellular 
levels of specific RNA species 
Here I present the results of a global survey designed to identify the full subset of 
cellular factors in the budding yeast, Saccharomyces cerevisiae, that impact the 
efficiency of pre-mRNA splicing. As a complement to other recently described genetic 
and physical genome-wide approaches, in this work I have developed an approach that 
allows for a direct readout of the accumulation of specific RNA species in the 
background of thousands of different mutant strains. An important strength of a 
genome-wide screen such as this is its unbiased approach. By directly measuring the 
splicing efficiency of endogenous transcripts, this method avoids bias generated using 
reporter constructs. Moreover, the ability to examine numerous different transcripts 
allowed to distinguish the natural variation in the spliceosomal factors that are 
required for efficient splicing of different intron-containing transcripts. Indeed, by 
systematically examining the precursor levels in the background of each strain, 
mutations can be identified which result in a change in splicing efficiency regardless 
of their previously described functions. In the work described here, mutations in 
scores of genes with no previously known role in splicing were identified, some of 
which impacted the splicing of all five canonical transcripts examined and some of 
which impacted only a subset of them. While some of these factors have been further 
characterized and discussed here, many have not. To be sure, as is the case with all 
genetic screens, it is impossible on the basis of these screen data alone to ascribe a 
direct role for any of these candidate factors in the splicing pathway. Rather, the 
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identification of these different factors can be seen as generating a rich dataset from 
which hypotheses can be generated and tested for their mechanistic underpinnings. 
 
2.4.2 The 5’ end: connecting splicing with chromatin remodeling and 
transcription initiation 
Beyond known splicing factors, the most highly over-represented set of factors 
identified in this work function in chromatin remodeling. One particularly interesting 
mutation that was identified was the bdf1Δ mutant. In budding yeast, Bdf1 has been 
demonstrated to play a role precisely at the interface of transcription initiation and 
chromatin remodeling. Based in part on its physical interaction with the Taf7 subunit 
of TFIID, yeast Bdf1 has been proposed to function as the missing C-terminal portion 
of the higher eukaryotic TAFII250 [41], the largest subunit of the TFIID complex. 
More recently, it has become clear that Bdf1 interacts with Swr1 and functions in 
recruiting the entire SWR1 chromatin remodeling complex to nucleosomes. A recent 
genome-wide study demonstrates that Bdf1 is enriched on the +1 and +2 nucleosomes 
of actively transcribed genes [47], and that it coincides with the localization of Vps72, 
another component of the SWR1 complex, and another component which was 
identified in our screen (Figure 2.11).  
Remarkably, the splicing of nearly every intron-containing gene is negatively affected 
in a bdf1Δ strain, and the quantitative defect seen in this mutant rivals that seen for 
canonical splicing mutants. Given its role in global gene expression, one possible 
explanation for our results in the bdf1Δ strain is that the transcription of some key 
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splicing factor is repressed by this mutation, causing a decrease in splicing efficiency. 
Indeed, early work on Bdf1 from the Séraphin lab suggested a role in global 
transcription, including transcription of the spliceosomal snRNA genes [48]. However, 
my microarray analyses show essentially normal RNA levels of all known splicing 
components in the bdf1Δ strain (see Figure 2.15). Moreover, the microarray data 
assessing the snRNA levels themselves are entirely consistent with Séraphin’s original 
observations and demonstrate that none of the five wild type snRNAs are decreased in 
cellular level during growth at 30°C in the bdf1Δ mutant; rather, there are subtle 
increases in the U1 and U2 snRNA levels. Importantly, the ChIP-QPCR experiments 
in the bdf1Δ strain demonstrate a decreased occupancy of the U1 snRNP on all four 
intron-containing genes that were tested, suggesting the intriguing possibility that 
Bdf1 plays a direct role in connecting pre-mRNA splicing with chromatin remodeling 
and transcription initiation.  
In considering such a role for Bdf1, it is important to note that the yeast BDF1 gene 
has a close sequence homolog in the BDF2 gene. These two genes are genetically 
redundant, in so much as both single gene deletions are viable but the double mutant 
bdf1Δ/bdf2Δ is lethal. Moreover, it has been shown that these two genes evolved from 
a single ancestral gene following a whole-genome duplication event [49]. Yet 
surprisingly, unlike the bdf1Δ strain, the bdf2Δ strain showed no signs of a splicing 
defect either in the screen or when examined by splicing sensitive microarrays. 
Moreover, unlike the bdf1Δ strain, there was no apparent decrease in U1 snRNP ChIP-
QPCR signal in the bdf2Δ strain. In considering a mechanism whereby Bdf1 connects 
transcription initiation and chromatin remodeling with pre-mRNA splicing, it is worth 
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noting that, unlike human genes, the majority of yeast genes do not contain an intron. 
As such, co-transcriptional recruitment of the spliceosome is unnecessary for most 
yeast genes. I am considering the possibility that, in the time since the duplication 
event, Bdf2 has evolved to a point where it retains the capacity to recruit RNA 
polymerase but has lost the ability to efficiently connect splicing with transcription. 
Such a scenario would explain the differences observed between the bdf1Δ and bdf2Δ 
microarrays and U1 snRNP ChIP-QPCR data. It would also likely explain the 
previously published results that Bdf1 shows higher sequence conservation with the C-
terminal domain of human TAFII250 than does Bdf2 [41]. Given such a model for the 
divergence of Bdf1 and Bdf2 functions, the differences in protein sequence between 
these two proteins may prove informative for deciphering the mechanism of Bdf1 
activity. 
 
2.4.3 The 3’ end: connecting splicing with cleavage and polyadenylation 
In addition to the over-representation of factors marking the 5’ end of genes, the 
screen identified a number of factors involved in the 3’ end processing of mRNAs. 
Splicing-sensitive microarrays confirm a broad splicing defect in a mutant of Yth1, the 
homolog of human CPSF30, and transcript-specific splicing defects in mutants of Cft2 
and Fip 1, the homolog of human CPSF100 and a component of the polyadenylation 
factor complex PF I, respectively. In higher eukaryotes, components of the 3’ end 
processing machinery have been shown to physically associate with components of the 
U2 snRNP [50] and U2AF65 [51]; moreover, in vitro studies demonstrate a functional 
link between the pre-mRNA splicing and 3’ end processing pathways [52]. The 
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interactions between these two pathways in mammalian systems have led to the 
proposal that the 3’ end machinery plays an important role in terminal exon definition. 
Whereas the exon-definition model for mammalian spliceosome assembly posits that 
internal exons are defined by interactions between U1 and U2 snRNP components 
across an exon [53], definition of terminal exons is achieved by interactions between 
the 3’ end processing machinery and the U2 snRNP (Figure 2.17), imposing a 
functional connection between the pathways. Yet because of the relatively short length 
of S. cerevisiae introns and the limited number of genes that are interrupted by 
multiple introns, splicing in yeast has long been considered to proceed through a 
model of intron-definition. Nevertheless, the Keller lab recently demonstrated that 
some conditional alleles of YSH1/BRR5 lead to a decrease in splicing efficiency [54]. 
By identifying additional pre-mRNA splicing defects in the background of  other 
mutants in 3’ end processing suggests the intriguing possibility that some of the basic 
interactions that facilitate exon-definition in higher systems may also be present in 
budding yeast. Indeed, further characterizing the mechanism by which these 3’ end 
processing factors are affecting splicing in yeast may provide important insights into 
the mechanisms by which exon-definition is accomplished in higher eukaryotes. 
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Figure 2.17: The location of mutants that disrupt splicing suggests a similarity to 
exon-definition in mammalian splicing 
A. Spliceosome assembly in mammalian systems is thought to occur via exon-
definition, where interactions between U1 and U2 snRNP components across an 
internal exon, or CPSF components and U2 snRNP across a terminal exon, are 
necessary for efficient processing of the upstream intron. 
B. Functional location of a subset of the mutants examined in this work, presented on 
a model transcript. Factors shown in red caused a statistically significant increase in 
the precursor levels of at least one transcript in our screen, whereas those in grey did 
not affect the splicing of any of the transcripts. 
 
2.4.4 A global perspective 
An important strength of an approach such as this is the genome-wide perspective that 
it provides. Figure 2.17B shows a model of an idealized transcript along with the 
 78 
functional location of a subset of the factors that have been examined in the screen. It 
is striking to note that many of the factors identified here function both during 
transcription initiation (Bdf1 and others) and termination (Yth1, Cft2, Fip1, and 
others), thereby defining the beginning and ends of the first and last exons, 
respectively. In this work, I have identified not only those factors whose disruption 
leads to a functional defect in splicing efficiency, but in many cases the specific 
transcripts whose splicing is affected. 
More broadly, the work presented here demonstrates the feasibility of quantitating 
cellular RNA levels in the background of large mutant strain collections. While the 
current approach examined splicing efficiency in the context of optimized growth 
conditions, a similar approach could be applied to identify factors necessary for 
efficient splicing under varying cellular or developmental growth states. Likewise, 
although my work focused on the levels of several pre-mRNA species, this 
methodology should be directly applicable to assessing the levels of nearly any 
cellular RNA of interest. 
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CHAPTER 3 
 
A HIGH-THROUGHPUT MUTAGENESIS STRATEGY IDENTIFIES RESIDUES 
IN THE C-TERMINAL TAIL OF BDF1 THAT MAY BE IMPORTANT FOR ITS 
ROLE IN PRE-mRNA SPLICING 
 
3.1 Introduction 
The eukaryotic cell is a complex environment in which functional pathways are 
closely interconnected to allow for optimal decision making processes under normal 
growth conditions or in response to environmental cues. The study of a single protein 
within a pathway involves both the detailed study of its functional domains as well as 
its integration in the broader network of interactions it makes with other cellular 
factors. Several genome-wide techniques have started to characterize global genetic 
and physical interaction networks, giving us a better perspective on how different 
factors can link multiple cellular pathways. In yeast, current methods like synthetic 
genetic arrays (SGA) [1] and Epistatic Miniarray profiling (E-MAPs) [2] aim to 
uncover the underlying genetic interactions based on the cellular fitness of double 
mutants, whereas proteomic studies [3-5] seek to place a certain factor within a 
complex by mapping its physical interactions. The more targeted analysis of 
functional domains has historically involved deleting or exchanging protein domains, 
identifying the interactors of a certain domain by yeast two hybrid analyses and 
affinity purification, and then using specific mutations to assess the function of 
important residues within the domain. Nevertheless, creating deletion mutants and 
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chimeric constructs can be time consuming may not readily offer answers when a 
combination of domains within a protein are required for a specific function. 
The Bdf1 protein functions at the border of transcription and chromatin remodeling, as 
a subunit of yeast TFIID [6]. Through its interaction with Taf7, Bdf1 recruits RNA 
polymerase II to TATA-less [7, 8] promoters, which represent 80% of yeast 
promoters. Bdf1 maps to the C-terminal part of its mammalian homologue TafII250 
and is a protein of the BET family, containing 2 bromodomains and a C-terminal ET 
(extra terminal) domain. Through its two bromodomains which recognize acetylated 
lysines on histone tails [9, 10], Bdf1 specifically binds hyperacetylayed histone H4 in 
vitro [11, 12] and in vivo [13, 14]. In addition to its function in transcription, Bdf1 co-
purifies with the yeast SWR-C complex [15-17], which is responsible for exchanging 
histone H2A with histone H2A.Z (Htz1 in yeast) at promoters genome-wide. It was 
shown that Bdf1, Taf1 (TFIID) and Htz1 global occupancy is highly correlated [18] 
and that this correlation is dependent on the Esa1 acetyltransferase. Moreover, Bdf1 
colocalizes with the +1 and +2 nucleosomes genome-wide [19], together with another 
SWR-C component, Vps72.  
Interestingly, Bdf2 is a Bdf1 homologue which emerged following a whole-genome 
duplication event [20]. Deletion of either Bdf1 or Bdf2 is viable, but deletion of both 
copies leads to a synthetic lethal phenotype. Similarly to Bdf1, Bdf2 can interact with 
Taf7. However, whereas Bdf1 prefers H4 hyperacetylated tails, Bdf2 binds with equal 
affinity to all H4 species [11, 12]. Moreover, Bdf1 and Bdf2 occupy distinct genomic 
locations, although Bdf2 is upregulated upon Bdf1 loss and can bind some Bdf1 
specific promoters [7]. 
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In the previous chapter, I reported that that bdf1Δ but not bdf2Δ leads to global 
splicing inhibition in budding yeast, suggesting that while both proteins play a role in 
transcription, only Bdf1 maintains a role in pre-mRNA splicing. Here I present a 
modified version of the high-throughput assay I employed, which allows for fast 
screening through thousands of mutations generated in a protein of interest and leads 
to the rapid identification of protein regions involved in a particular process. In a pilot 
test, I employed this method to screen through multiple Bdf1 mutants and identify 
specific mutations that cause the pre-mRNA splicing defect in a bdf1Δ strain. I show 
that these mutations are distributed to two main regions of the protein – at the N and 
C-terminus. While most of the N-terminal mutations fall in the region of a predicted 
coiled coil which is more permissive to mutations, the C-terminal mutations lead to 
the truncation or modification through frameshift of the C-terminal acidic domain. 
Fascinatingly, this region overlaps with Bdf1's interaction domain with Taf7 and, 
moreover, with a region of Bdf1 phosphorylation and the C-terminal acidic SEED 
sequence.   
 
3.2 Materials and Methods 
3.2.1 Plasmid and strain construction 
Bdf2 containing the ORF and about 500 base pairs of the 5’ and 3’ UTR was 
amplified off wild-type yBY4741 [21]. S. cerevisiae genomic DNA using the high 
fidelity Phusion polymerase (NEB cat#: M0530S) as per manufacturer’s instructions 
(Denature: 98C 30sec; 30 cycles of 98C 10sec, 60C 20sec, 72C 1min; Final extension 
72C 10min). The primers used to amplify the fragment are listed in Table 3.1 and were 
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phophorylated with T4 polynucleotide kinase (NEB cat#: M0201S) prior to the PCR 
reaction. Similarly, the Bdf1 ORF containing 111bp of the 5’UTR and 48bp of the 
3’UTR (a 2259 bp product) was amplified using phosphorylated primers off the same 
yBY4741 genomic DNA. The URA marked pRS416 (see the ATCC collection, 
www.ATCC.org) CEN and pRS426 2-micron plasmids were linearized using SmaI 
(NEB cat#: R0141S), dephosphorylated with Antarctic phosphatase (M0289S) and 
purified off a 1% agarose gel. Similarly, the Bdf1 and Bdf2 fragments were gel 
purified. The Bdf1 fragment was cloned into the pRS416 vector, whereas the Bdf2 
fragment was inserted into the pRS426 backbone using T4 ligase (M0202S). The 
plasmids were extracted out of bacteria and sequenced to confirm the quality of the 
integration.  
 
Table 3.1: Primer sequences used in this study for cloning and qPCR 
 
Target Forward primer Reverse primer 
Bdf1 111bp 
upstream, 48bp 
downstream of 
ORF 
(mutazyme 
primers) 
TAATTAAGCCTACTGGGTCGCTC
C 
GGTGCTCATTCTTCTCAGTCGTT
G 
Bdf2 ~500bp 
upstream and 
downstream of 
ORF 
AGTATAATGTGACGTGGTTACCT
TGG 
TTAGATCGAGCTCGAGTAGTGA
ACAT 
Bdf1-SmaI (1st 
fragment) 
AACTGTACCTGAGTGGCTCAAAT
AGC 
GAAGATAATCAAATTCAAAATT
CAGCCCGGGTACGTACGTTTATC
AGAGCCGTTGA 
Bdf1-SmaI (2st 
fragment) 
TCAACGGCTCTGATAAACGTACG
TACCCGGGCTGAATTTTGAATTT
GATTATCTTC 
GAACTGCTACTGAATCCCTCAG
ACAT 
Bdf2 qPCR 
AATACCTTTTAAGCTCCATTAAG
GCGACC 
GGCTTCAGAAACGGTCTAGCAT
CTTTTAAT 
 
 
In budding yeast, mutagenized templates can be introduced into a backbone which 
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contains sequences which are homologous to the ends of the fragment through 
spontaneous recombination. This process is known as gapped repair [22] and occurs 
when both the fragment of interest and the linearized backbone are co-transformed 
into a yeast cell. In this approach, a pool of such fragments were transformed into a 
population of yeast cells, thus generating a pool of strains in which each strain 
contains a unique mutated version of Bdf1 on a plasmid. 
To obtain a recombination template for gapped repair (from now on referred to as 
Bdf1-SmaI:pRS413), ~500 bp upstream and downstream of the Bdf1 ORF were 
amplified and stitched together by PCR, using the overlapping primers in Table 3.1 to 
create a SmaI restriction site in the middle of the fragment. Two independent PCR 
reactions (Bdf1-SmaI) amplifying ~500bp of the 5’UTR and the ~500bp of the 3’UTR 
were run with Phusion polymerase following the manufacturer’s instructions for 30 
cycles then the products were gel extracted and 2ng of each product mixed together. A 
10 cycle 20 µl reaction with the mixed template but lacking the external primers was 
run under the same conditions as above to allow for the annealing and extension of the 
fused template. Then, 1µl of this reaction was diluted in a 50 µl reaction with Phusion 
polymerase in which external phosphorylated primers were used to amplify the 
stitched fragment. The pRS413 vector (ATCC) was linearized with SmaI, 
dephosphorylated and used to clone in the fragment containing ~500bp of the 5’ and 
3’UTR of Bdf1. Selection was performed on plates lacking histidine.  
In addition, a Bdf1-Kan fragment was amplified using the same Bdf1 (mutazyme) 
primers listed in Table 3.1 from bdf1Δ genomic DNA and introduced into Bdf1-
SmaI:pRS413 by gap repair. To this end, the Bdf1-SmaI:pRS413 vector was cut with 
 89 
SmaI, dephosphorylated and purified by gel extraction, then mixed stoichiometrically 
with a purified Bdf1-Kan fragment. This mix was used in a regular yeast 
transformation reaction in a yBY4741 (WT) background and colonies were selected 
on SD-His media. The plasmids were then extracted out of saturated yeast cultures, by 
first degrading the cell wall with lysozyme and then by performing a customary 
bacterial prep. These were then transformed into competent DH5α strains and a 
bacterial stock of the plasmid prepared.   
The yBY4741 bdf2Δ MATα strain from Open Biosystems was used to construct the 
bdf1Δ bdf2Δ Bdf2:pRS426 strain in which the gap repair reactions for obtaining Bdf1 
mutants were performed. To this end, first the KanMX marker cassette which marks 
the Bdf2 deletion was exchanged with the NatMX (nourseothricin) marker by using 
the standard lithium acetate transformation procedure (ref). The bdf2Δ::NatMX 
Bdf2:pRS426 strain was generated by standard transformation techniques and colonies 
were selected on minimal media lacking uracil.  The Bdf1-Kan:pRS413 vector was 
restriction digested with BamHI (R0136S) and EcoRV-HF (R3195S) and 1-2 µg 
amounts were used to knockdown Bdf1 in the bdf2Δ::NatMX Bdf2:pRS426 
background. The bdf1Δ::KanMX bdf2Δ::NatMX Bdf2:pRS426 strain was selected on 
YPD (ref) +G418+Nat and then tested on SD-Ura and 5-FOA. 
The Bdf1:pRS416 vector was used as a template in the Mutazyme PCR (Agilent 
technologies cat#:200550). The reactions were run as indicated in the manufacturer’s 
manual, by testing different input amounts and varying the number of cycles. Thus, for 
the “low” mutation rate reaction 5ng of a purified Bdf1 fragment (111bp upstream, 
48bp downstream of ORF) were used and 20 PCR cycles were run. Conversely, for 
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the “medium” and “high” mutation rate 100 and 300ng of template were used 
respectively and 30 cycles of amplification were performed. In parallel, a control 
reaction using Phusion polymerase was run, and 5% of the amplification products run 
on a 1% agarose gel to check the correct size.  
The PCR products were then mixed with DNA binding buffer (5M Guanidine-HCl, 
30% Isopropanol), bound to a Zymo5 (cat#: C1003-250) column and washed twice 
with Wash Buffer (80% Ethanol, 10mM Tris-HCl). The column purified products 
were integrated by gap repair into the Bdf1-SmaI:pRS413 vector, leading to the 
formation of a Bdf1 mutagenized ORF flanked by ~500bp of native UTR sequences 
on either side. The gap repair reactions were initially performed in a yBY4741 strain 
in order to empirically check the mutation rate under the 3 conditions. In this case, the 
yBY4741 strain was grown in rich media (YPD) at 30°C and the cells were allowed to 
recover O/N in 5ml SD-His media before plating onto SD-His agar plates. To obtain 
Bdf1 mutants for the screen, the gap repair was performed in the bdf1Δ::KanMX 
bdf2Δ::NatMX Bdf2:pRS426 strain. Given that the cell needs to retain a functional 
Bdf copy for viability (in this case Bdf2), this strain was also grow in rich media but at 
25°C (bdf1Δ is temperature sensitive) and allowed to recover overnight (26h) in 60ml 
of SD-His media. Then 5ml aliquots were spun down and plates onto 5-FOA plates to 
achieve the shuffling out of the Bdf2:pRS426 plasmid.  
Serial dilutions of strains were done by growing them until mid-log phase 
OD600nm=0.5 in rich media (YPD) then, diluting them in sterile MilliQ water to 
OD600nm= 0.1 and making 6 4-fold serial dilutions. The strains were then pinned onto 
YPD or selective media and allowed to grow at different temperatures. 
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3.2.2 High throughput strain handling, RNA extraction, cDNA conversion and 
qPCR 
Bdf1:pRS413 bdf1Δ bdf2Δ strains together with a couple of bdf1Δ positive and bdf2Δ 
negative controls were hand-picked off 5-FOA selection plates and set to grow to 
saturation in a 96-well plate (USA Scientific cat#:1896-1110) in 500ml YPD at 25°C 
for 2 days. At this time, a glycerol stock at a 15% final glycerol concentration was 
made and the plate was stored at -80°C. The strains were pinned onto solid YPD 
media using a 96-well pinner tool, allowed to grow for 1-2 days in the 25°C incubator, 
then transferred into positions A1 and A2 (every other row) of a 384-well plate 
(Greiner BioOne cat#:781271) containing 150 µl YPD. The rest of the plate was filled 
with a diluted yBY4741 (WT) culture. The plate was sealed with adhesive breathable 
tape (VWR cat#: 600941-086) and allowed to grow for 2 days at 25°C 250rpm. Using 
robotic protocols previously developed (see Chapter 2, Methods), the saturated 
cultures were mixed and 2 µl of the saturated culture was freshly diluted into a new 
384-well plate containing 150 µl YPD/well. The cultures were allowed to grow for 4h 
at 30°C 900rpm, then collected through centrifugation at 4000*g for 5 minutes. The 
plates were flash frozen in liquid nitrogen and stored at -80°C. 
Robotic RNA isolation, cDNA conversion into cDNA and high-throughput qPCR was 
performed as described in chapter 2, with the exception that all protocols were 
modified to accommodate one plate per extraction instead of two. qPCR was 
performed using the U3 precursor primers to measure the species of interest and FAA1 
primers as a control. Data analysis was performed as described in Chapter 2 with the 
difference that the CV filter was applied only to the FAA1 primer pair and the FAA1 
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RNA levels were used to normalize the RNA amount in each well instead of a 
composite normalization constant. The SAM analysis to determine statistical 
significance was performed as described before and the delta values was chosen to 
minimize FDR (Δ=1.38, FDR=0). 
 
3.2.3 Culture growth, RNA extraction and cDNA synthesis for small scale qPCR 
The strains were grown overnight in rich media (YPD) at the permissive temperature 
of 25°C, then back-diluted the following morning at an OD600nm=0.05 and outgrown 
in YPD at 30°C until they had undergone at least two doublings (OD600nm=0.3-0.5). 
The strains were collected by filtration under vacuum using Millipore filters (Millipore 
cat #:HAWP04700), flash frozen in liquid nitrogen and stored at -80°C. 
Total RNA was extracted using the hot phenol method. The pellets were resuspended 
in equal amounts of Acid phenol (pH<5.5) and AES buffer (50mM NaAcetate pH 5.3, 
10mM EDTA, 1% SDS), and incubated in a 65°C water bath for 7 minutes, vortexing 
every minute. The samples were then  loaded onto prespun 15mL PhaseLock Gel 
Tubes (Fisher Sci cat#: FP2302850) and spun in an X 15R/SX4750A rotor centrifuge 
at 4750rpm for 5 min. The RNA was back-extracted with Phenol:Chloroform:IAA 
(25:24:1), followed by Chloroform. Total RNA was precipitated with 3M NaOAc pH 
5.3 in the presence of 100% isopropanol then spun for 20min at 14K at 4°C in a 
tabletop centrifuge. The pellet was washed twice with 70% ethanol then dried in a 
vacuum concentrator. The pellets were resuspended in sterile MilliQ water to a 
concentration of 1-2µg/µl.  
5 µg of total RNA was DNase treated at room temperature for 15 min with 2 µl of 
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DNase Mix (1x DNase Buffer, 0.25 units of DNase I (Promega)). The samples were 
then mixed with RNA biding buffer (2M Guanidine-HCl, 75% isopropanol) and 
bound to Zymo-5 columns (C1003-250). The columns were spun at 14K for 1 minute 
in a tabletop centrifuge then washed twice with RNA wash buffer (80% Ethanol 
10mM Tris-HCl). A final dry spin prior to elution was performed for 2 min at 14K. 
Total DNase trated RNA was eluted into 10 μl sterile MilliQ water. The 10μl were 
used in a cDNA synthesis reaction that had a total volume of 40µl and which 
contained 50mM Tris-HCl (pH8.3), 75mM KCl, 3mM MgCl2, 10mM DTT, 0.5mM 
each dNTP, 5µg dN9 primer, and 60ng M-MLV RT. Reactions were incubated for 2h 
(>99% reaction completion) or overnight at 42°C. 
 
3.2.4 qPCR 
The cDNA reactions were diluted to 2ng/μl based on the initial RNA concentration 
and used without any further purification as templates in quantitative PCR (qPCR) 
reactions. The qPCR reactions were performed in a reaction volume of 15µl, 
containing 5µl of template (~10ng of template), 10mM Tris-HCl (pH8.5), 50mM KCl, 
1.5mM MgCl2, 0.2mM each dNTP, 0.25x SYBR Green, 5% DMSO, 0.7ng Taq DNA 
polymerase, and 250nM forward and reverse primers. The sequences of the primers 
used for measuring Bdf2 levels are shown in table 3.1, whereas the sequences for 
amplifying the U3 precursor and the FAA1, SCR1 and Tub1 normalization genes were 
discussed in Chapter 2. 
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3.3 Results 
3.3.1 A forward genetic high-throughput method to identify mutants which 
impact total transcript levels  
In the previous chapter, I described a quantitative approach I have developed to assess 
global changes in transcript levels in the budding yeast Saccharomyces cerevisiae. 
This method allowed me to screen through a known collection of mutants comprising 
over 93% of the budding yeast genome and identify trans-acting factors involved in 
pre-mRNA splicing. Among the top candidates, I identified factors involved in 
chromatin remodeling and transcription, and proteins belonging to the 3’end 
processing machinery which cause global or gene-specific splicing defects. One of the 
most promising candidates is Bdf1, a factor which has been characterized to actively 
function in transcription by recruiting RNA polymerase II, as well as in chromatin 
remodeling at the level of the promoter, by interacting with the SWR-C complex. In 
our study, Bdf1 caused a significant increase in the precursor levels of the splicing 
reporter U3 snoRNA (Figure 3.1A) and led to global defects in splicing as shown by 
splicing sensitive microarrays (Figure 3.1B). Intriguingly, Bdf1’s homologue Bdf2 
with which it shares significant homology (35% identity, 67% similarity) did not 
impact U3 precursor levels, nor did it cause detectable mis-splicing of intron 
containing genes on a genome-wide basis as determined by microarray analysis. 
Indeed, Bdf2, which resulted following the whole-genome duplication event in yeast, 
shares the domain structure of Bdf1, including the two bromodomains (52-56% 
identity, 86-91% similarity) and the C-terminal ET (extra terminal) acidic domain. 
Nevertheless, despite these similarities, Bdf1 and Bdf2 have diverged and contain 
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several stretches of amino acids which are present in one protein, but not the other. 
Most significantly, these differences in protein structure enabled Bdf1 to maintain a 
role in pre-mRNA splicing which is absent in Bdf2. Therefore, one important question 
that remains to be addressed is how Bdf1 functions in pre-mRNA splicing and what 
residues within the protein are essential for this function. 
 
Figure 3.1: Mutagenesis rationale and identification of Bdf1 mutants which mimic 
bdf1Δ 
 
A. bdf1Δ upregulates U3 precursor levels similar to the bona-fide splicing mutants 
snt309Δ and lsm6Δ, in contrast to bdf2Δ. The data were generated in the context 
of ~5500 yeast mutants (see chapter 2) and are presented in log2 space. 
B. Splicing sensitive microarrays depicting the whole-genome splicing defect in 
bdf1Δ in comparison to the two splicing mutants snt309Δ and lsm6Δ, and in 
contrast with bdf2Δ. The genes are organized based on the clustering within the 
bdf1Δ array, and each row in all 4 arrays represents the same gene. 
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C. Schematic representation of the mutagenesis rationale to create yeast strains 
containing only a single mutagenized Bdf1 protein-. 
D. Pilot data from a plate containing 96 mutants and 96-wild type strains. The data 
was processed as described in Materials and Methods, and the expression values 
(in log2 space) were ordered from high to low. The data points within the S-curve 
represent the average of 4 experimental values. The top ranking highly-
reproducible candidates which passed the SAM analysis are highlighted in green. 
The location of the bdf1Δ positive control and the bdf2Δ negative control are 
shown in red and blue respectively.  
 
To identify the residues in Bdf1 which make it crucial for pre-mRNA splicing, I 
employed our previously published method in a forward genetic manner. To this end, I 
first mutagenized the Bdf1 gene using Mutazyme II (see Materials and Methods). The 
mutagenized Bdf1 product will be referred to from now on as Bdf1*. Mutazyme II is a 
mixture of enzymes which allows for substitutions of bases within the mutagenized 
fragment to occur with broadly equal preference for the four bases. Compared to other 
PCR mutagenesis approaches, the concentrations of dNTPs or Mg2+ are not varied. 
Instead, the amount of template in the reaction and the number of PCR cycles 
determine the mutation rates in the final product. To empirically test mutation rates, I 
used three different mutagenesis conditions – “high”, “medium” and “low” – and 
utilized the fragments in a gap repair reaction in order to construct Bdf1*:pRS413 
plasmids (HIS marked). Following recombination, these plasmids should contain ~500 
bp of the native 5’ and 3’UTR surrounding the mutagenized ORF. The mutation rates I 
empirically determined closely match the expected values (see Table 3.2), whereas a 
control reaction using Phusion polymerase led to zero mutations/product. In addition, 
the mutations were comprised of 13 transitions and 7 transversions. 
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Table 3.2: Expected versus observed mutation rates under different mutagenesis 
conditions 
 
 
Mutation frequency (mut/kb) 
 
Mutation rate Expected Observed 
Mutations/Bdf1 
gene (2.1kb) 
Low 0-4.5 0-3 0-5 
Medium 4.5-9 1.5-4.3 3-9 
High 9-16 4.3-7 9-15 
 
To screen for Bdf1 mutants which behave like a Bdf1 null, I chose the “medium” 
mutagenesis conditions to allow for a sufficient number of mutations within the 2.1kb 
Bdf1 gene and constructed Bdf1*:pRS413 bdf1Δ bdf2Δ strains. Since the double 
bdf1Δ bdf2Δ is not viable in yeast cells, a multi-copy 2-micron version of the Bdf2 
gene was introduced on a URA marked vector in a bdf2Δ background, after which the 
wild type chromosomal copy of Bdf1 was knocked out in this strain (see Materials and 
Methods). The Bdf2:pRS426 bdf1Δ bdf2Δ strain thus created was verified for its 
ability to grow on plates lacking uracil, and the double deletion was confirmed 
through resistance to both G418 and Nourseothricin. Next, I conducted gapped repair 
with a mutagenized Bdf1 pool and a HIS marked vector backbone in this strain 
background, followed by the shuffling out of the Bdf2 copy onto 5-FOA (see Figure 
3.1C and Materials and Methods). This approach ensures that the mutagenized Bdf1* 
is the only functional Bdf copy present in these cells, whose presence was confirmed 
by growth on plates lacking histidine. In addition, the strains were checked for the lack 
of ability to grow on plates lacking uracil, thus ensuring that they have indeed shuffled 
out Bdf2. These mutants were grown in 384-well plates together with wild type, 
positive (bdf1Δ) and negative (bdf2Δ) controls. The robotic methods discussed in 
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chapter 2 were employed to extract RNA, convert it into cDNA, and quantitatively 
measure U3 precursor level in all of these mutants by qPCR. Thus, our previously 
reported method can be employed to rapidly identify mutants within a target protein 
which cause changes in cellular RNA levels. 
 
 3.3.2 Testing and validation of Bdf1 mutants which cause U3 precursor 
upregulation 
In the original screen, in which I was globally searching for trans-acting factors which 
impacted pre-mRNA splicing, the general expectation was that the majority of ~5500 
yeast mutants play no role in splicing. In the current screen the hypothesis is similar, 
in that the majority of mutations would change residues in regions of Bdf1 which are 
conserved with Bdf2 and thus would have no role in splicing. Figure 3.1D shows the 
distribution of U3 precursor levels in 96 Bdf1*:pRS413 bdf1Δ bdf2Δ mutants and 96 
wild-type strains. As expected, the vast majority of the data sit within a ±1.5 fold-
change, with only a few candidates reproducibly causing a larger accumulation in 
U3precursor levels. The bdf1Δ positive control strain shows a 60% increase, which is 
lower than previously observed, while the bdf2Δ negative controls appear towards the 
bottom of this distribution and show a 50-60% decrease in total levels. Furthermore, I 
employed the SAM software (Significance Analysis of Microarrays, see Chapter 2) to 
test the statistical significance of the data which led to five candidates being called as 
causing a reproducible increase in U3 precursor levels at least at the level of bdf1Δ: 
K5, K17, O9, M13 and M15 (Table 3.3). 
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Table 3.3: SAM generated list of the top reproducible candidates 
 
The Score(d) is calculated by dividing the Numerator value (fold change) to the 
Denominator (a measure of the standard deviation within the replicates)   
 
Mutant Score(d) Numerator(r) Denominator(s+s0) 
O9 11.4273 0.9708 0.0850 
M15 10.9732 0.6783 0.0618 
M13 10.3015 0.9158 0.0889 
K5 4.9730 1.5840 0.3185 
K17 4.2383 1.2803 0.3021 
 
To further validate these results, I re-measured the U3 precursor levels by small scale 
qPCR (Figure 3.2A). All of these candidates except for one (M13) recapitulated the 2-
fold increase in U3 precursor levels observed in the screen. Upon sequencing, the 
candidates actually revealed three different mutation patterns, with two of the positive 
candidates having the same sequence (O9 and K17).  
Besides the candidate strains, I tested several strains which did not impact U3 
precursor levels in my pilot screen (negatives). Strains A1, A2, A3 and A5 did not 
show any increase in U3 precursor levels in the screen or led to a slight (10-20%) 
decrease from the median, showing a similar phenotype to the bdf2Δ strain. As 
expected, none of these strains showed an increase in U3 precursor levels larger than 
2-fold. However, A1 did exhibit an upregulation in U3 precursor levels of 0.75 on a 
log2 scale which is slightly larger than the variation I observed for bdf2Δ in multiple 
experiments. This begs the question of what degree of upregulation really constitutes a 
splicing mutant capable of mimicking the bdf1Δ phenotype and will need to be 
investigated with different assays. In addition to the strains from this particular 
experiment, I tested several negatives from a separate experiment (bottom panels, 
figure 3.2). Neither of the H4, D8 or L3 mutants caused a change in U3 precursor 
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levels larger than ~50%. 
 
 
 
Fig 3.2: Confirmation of candidate strains and negatives by small scale qPCR 
 
A. qPCR to measure U3 precursor levels in the candidates and negative strains. The 
values are normalized to a normalization constant calculated based on the FAA1, Tub1 
and SCR1 levels and expressed in log2 space. Representative experiments are shown 
and the standard error represents the error of technical replicates. 
B. qPCR to measure and Bdf2 levels 
C. Serial dilution of yeast strains grow onto YPD media at 37°C. The two panels at the 
bottom right show strains on the same plate.  
 
 
 101 
Further validation indicated that the Bdf2 levels in all strains were depleted at least to 
the extent of the bdf2Δ strain, indicating that the strains were indeed lacking a Bdf2 
copy (figure 3.2B). Moreover, Bdf2 was consistently upregulated ~2-fold in a bdf1Δ. 
All candidate strains were His+ Ura- (data not shown) and grew slowly at 37°C, 
regardless if the mutation caused an increase in U3 precursor levels or not (figure 
3.4C). Furthermore, the A1 mutant displayed a more severe sickness at 37°C than any 
of the other Bdf1 mutants. These observations suggest that Bdf1's role in splicing and 
the temperature sensitiveness of Bdf1 mutants are not correlated. This lack of 
correlation is not entirely surprising in the light of other Bdf1 mutants which were 
described by the Buratowski group. Thus, they have shown that multiple mutations 
which fall within the bromodomains cause ts phenotypes [12], as can mutations of 
serine residues which are normally phosphorylated in Bdf1 [23]. The mutations they 
describe fall in different regions of the Bdf1 protein - bromodomains versus IPR 
(internal phosphorylation region) and CPR (C-terminal phosphorylation region) - and 
do not seem to be linked to any one particular function of Bdf1.   
 
3.3.3 The Bdf1 mutations which mimic the bdf1Δ phenotype affect the distal C-
terminal region 
In order to determine the significance of certain mutations within a particular sequence 
context I took a comparative approach: I was interested in mutations which affect 
highly unique residues in Bdf1 when comparing Bdf1 with Bdf2, and which show 
high conservation with other Bdf1 homologues in sister Saccharomyces species. In 
addition, I was interested how these mutations map within different domains of the 
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Bdf1 protein (Figure 3.3A) and what was the likelihood of their disrupting the 
function of that domain. Thus, I first generated an alignment of Bdf1 and Bdf2. As 
shown in Figure 3.3B, despite the significant homology between the two homologues, 
there are certain regions in Bdf1 which are absent in Bdf2, as well as regions of lower 
conservation between the two, such as the N- and C-termini. Next, I aligned all 7 
Saccharomyces Bdf1 homologues using the information on the UCSC platform and 
derived a conservation trace (Figure 3.3C). Finally, I used both the Swiss Model [24, 
25, 26] and I-TASSER [27, 28] programs to generate the secondary structure 
prediction of Bdf1 and superimposed it with the conservation traces (Figure 3.3A). I 
then mapped the location of the mutants within all three contexts (Figure 3.3D).  
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Figure 3.3: The mutations in Bdf1 in the context of its primary and secondary 
structure 
A. Domain structure of Bdf1 - the domains are defined in terms of position and are 
colored, as opposed to the gray coiled coil area. Underneath, the secondary structure 
prediction from I-TASSER is aligned, where red represents an α-helix, blue a β-sheet 
and black the coiled coil. 
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B. Conservation diagram at the amino acid level for Bdf1 and Bdf2. The height of the 
graph is directly proportional to the conservation between the two proteins. Blue 
triangles represent deletions in Bdf1, whereas green triangles stand for deletions in 
Bf2. 
C. Conservation trace generated by the UCSC platform, representing the alignment 
between S. cerevisiae Bdf1 and 6 other Saccharomyces species.  
D. Location of the mutations in the three top candidates with respect to Bdf1's protein 
structure. The altered sequence as a result of the frameshift in the K5 mutant is 
presented underneath the grey Bdf1 native sequence. 
E. Conservation of the C-terminal end comprising the CPR (660-670) and SEED 
regions in Bdf1 homologues as opposed to Bdf1/Bdf2. 
 
A comprehensive list of mutations (including silent mutations) generated by Sanger 
sequencing of all plasmids is provided in Table 3.4. 
 
 
Table 3.4: The complete list of Bdf1 mutants  
 
All mutated amino acids are reported. If the mutants contain a change in a specific 
residue the change is noted and is compared with the residue in Bdf2. The 
conservation within Bdf1 and Bdf2 for a residue is noted, as well as the underlying 
secondary structure (coil or helix) and whether the residue falls within a specific 
domain. The IPR (internal phosphorylation region) occurs right after the second 
bromodomain, but before the B box, whereas the CPR (C-terminal phosphorylation 
region occurs after the NET domain but before the terminal SEED sequence (also see 
Figure 3.3) Silent mutations which occur in the wobble position of the codon are noted 
in grey.   
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Mutant 
Posi
tion 
Amino 
acid 
Muta
tion 
Bdf2 
equivalent 
Conserved 
in Bdf1 
Conserved 
in Bdf2 
Secon
dary 
struct
ure  Domain 
K5 24 S N A 5/5 5/5 C No 
 
62 L L 
     
 
69 L L 
     
 
208 A T V 7/7 4V/T/2A C 
BD1 (coil 
between αA 
and αB) 
 
228 D D 
     
 
551 I V I 5I/C/V 4I/V H NET 
 
608 T R no 6T/V 
 
C No 
 
660 P Frameshift 
   
acidic tail; 
becomes 
more positive/ 
hydrophobic/ 
excludes CPR 
K17 96 D E L D/K/3E 5/5 C No 
 
555 I L I 7/7 5/5 H NET 
 
560 P A P 7/7 5/5 C 
NET 
(between 2 α 
helices) 
 
661 G C no 4G/R/T 
 
C CPR 
 
664 Q STOP no 4Q/R/G 
 
C 
cuts off very 
acidic tail 
excludes CPR 
  671 F F           
M15 49 L L 
     
 
74 I I 
     
 
252 L L 
     
 
494 R C H 7/7 H/R/S/2Y C 
No (after B 
box, before 
NET) 
 
578 H Q A 
4H/Y/E/S 
(within 
conserved 
domain) A/E/2G/R H NET 
  656 Q STOP N 6Q/F 4/4 C 
No; cuts off 
acidic tail  
excludes CPR 
A1 245 A D K 7/7 
K/2T/L/I/2
A H BD1 (αC) 
M13 61 A T G 4A/I 4G/D C No 
 
76 G D D 3G/D/S 5/5 C No 
 
159 L F S 4L/S/M/T 2S/3N/M/T H BD1 
 
233 N K E 
5N/2T  less 
conserved 5E/2T C 
BD1, between 
αB and αC 
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within the 
bromodom
ain 
 
358 V I V 7/7 3V/4I C 
BD2 (within 
αA) 
 
377 Q H K 6Q/E 3K/2E/S/Q C 
BD2 (right 
before αB) 
  669 N N           
A2 
(same 
as M13 
plus 
one) 685 E H S 7/7 4/4 C 
final acidic 
domain 
A3 16 N N 
     
 
28 R K A 5/5 5/5 C No 
 
38 G V S 5/5 3/3 C No 
 
426 D N E 3D/4E 5E/P/D C 
No (right 
after BD2, 
before IPR) 
 
465 E G E 7/7 7/7 H 
in the very 
conserved B 
box domain 
  563 S C S 6S/G 4S/P C 
between H 
and a beta 
sheet in NET 
A5 211 V I S 
3V/F/A/T/
S 6S/T C 
BD1 (right 
before αB) 
  665 S R no 5S/I/L   C in CPR 
D8 41 E V S 5/5 3/3 C No 
 
49 L L 
     
 
58 D E D D/4N 4D/1V C No 
 
69 L R D 4L/1P 5/5 C No 
 
373 D D 
     
  621 S S         
 
H4 107 G R S 
2G/2E/miss
ing 5/5 C No 
  685 E STOP S 7/7 4/4 C 
final acidic 
tail 
L3 194 P P 
     
 
531 D G D 6D/1N 5/5 H NET 
 
The K5 mutant contains 5 non-silent mutations (figure 3.3D). The first one, S24N 
occurs in a coiled coil terminal region that is not conserved between Bdf1 and Bdf2 (S 
versus A), but in which the S and the A are conserved in Bdf1 and Bdf2 respectively. 
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However, as discussed below, this N-terminal coiled coil region seems more 
permissive to mutations that do not impact U3 precursor levels. The A208T mutation 
is located in a coiled coil region between helix αA and αB in bromodomain 1 (BD1). It 
is highly conserved in Bdf1 whereas the Bdf2 homologue has a valine at this position. 
Nevertheless, two other species of Saccharomyces (S. castelli and S. kluyveri) also 
have an alanine in this position in Bdf2, which could suggest that this residue has a 
similar role in Bdf1 and Bdf2. Another mutation in this mutant is I551V. However, 
Bdf1 and Bdf2 share the same residue at this position and therefore this mutation is 
unlikely to be relevant from a splicing perspective. The fourth mutation in this mutant 
occurs at position 608, T608R, which switches a hydrophobic residue to a positively 
charged one. The threonine residue is highly conserved in Bdf1, but has no 
correspondence in Bdf2. Given that this residue maps to a deletion in Bdf2, it is - a 
strong candidate to be of functional significance for the role  of Bdf1 in splicing. 
Lastly, there is a frameshift at position 660 in Bdf1 which deletes one of the 
phosphorylation regions in Bdf1 (CPR) and also the SEED terminal domain which is 
highly conserved in Bdf1 and is enriched in E, D and S residues.  
The K17 mutant contains a D96E mutation which leads to no change in the charge of 
this residue. In addition, this residue is not highly conserved between Bdf1 species, 
where D and E are highly interchangeable. Moreover, two other mutations present at 
I555L and P560A are unlikely to be of importance from a splicing point of view, 
because these residues are identical in Bdf1 and Bdf2 and highly conserved in both 
homologues. Therefore, a mutation in one of these residues would likely cause 
identical phenotypes in Bdf1 and Bdf2. More interestingly, two other mutations in this 
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Bdf1 mutant fall in a region of Bdf1 that maps to a missing region in Bdf2. Thus, 
G661C maps to a relatively conserved region within the CPR, while the other 
mutation inserts a stop codon at position 664. This stop codon cleaves off part of the 
CPR and the highly conserved SEED region. 
Finally, there are three mutations in the M15 mutant. The first one, R494C, occurs in a 
highly conserved residue within a coiled coil after bromodomain 2 (BD2). The residue 
is not conserved within Bdf2 homologues, although the S. paradoxus Bdf2 homologue 
contains an R at this position. Furthermore, a second mutation, H578Q, occurs in a 
non-conserved residue within the NET domain of Bdf1, while the third mutation at 
position 656 introduces a stop codon, again cleaving off the CPR and the acidic tail.  
Thus, all three mutants that cause an upregulation in U3 precursor levels contain either 
a non-sense mutation or a frameshift that leads to the removal of the C-terminal 
phosphorylation domain and of the highly acidic SEED domain.  
Among the negatives, D8 has several mutations within the N-terminal coiled coil 
which either occur in very conserved (E41V, L69A) or in less conserved residues 
(D58E). This suggests that the N-terminal coiled coil is more permissive to mutations 
and that this region is likely not very important for Bdf1's involvement in splicing. 
Furthermore, the H4 mutant contains a mutation in a non-conserved residue, G107A, 
in the N-terminal coiled coil and a second one which leads to a stop codon in the next 
to last amino acid of Bdf1. Despite its position in the very conserved SEED sequence, 
this mutation only shortens the protein by one amino acid. The third mutant, L3, 
contains a single mutation, D531G, at a well conserved position in the NET helix. 
Nevertheless, the same residue is highly conserved in Bdf2 as well, and it is likely to 
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therefore affect both proteins in a similar fashion. 
M13 is the only false positive mutant, which failed to re-test in the small scale qPCR. 
It contains three mutations within the N-terminal coiled coil (A61T, G76D and 
L159F). It also contains one mutation within BD1 (N233K) and two mutations within 
BD2 (V358I and Q377H), all of which appear to have no impact on U3 precursor 
levels. Moreover, the A2 mutant is nearly identical with M13, containing only one 
additional mutation, E685H, which was shown in the H4 mutant to be aphenotypic.  
The last negative strain, A3, contains mutations that either maintain the original 
charge of the amino acid (R28K), or that occur in residues that are highly conserved 
between Bdf1 and Bdf2 (E465G, S563C) and therefore are unlikely to impact a Bdf1 
specific function. Another mutation in the N-terminal coiled coil (G38V), as well as 
one after BD2 (D426N), are likely not important for the Bdf1 splicing phenotype. 
Interestingly, the A5 mutant does not cause a significant increase in U3 precursor 
levels, despite a mutation (S665R) in the CPR domain.  
Lastly, mutant A1 contains a single mutation (A245D), within the αC helix of BD1, in 
a highly conserved residue in Bdf1. The importance of this mutation will need to be 
addressed in future experiments, since a 2-fold increase in U3 precursor levels is not a 
clear cut measurement which guarantees  a splicing phenotype. Therefore, it is unclear 
if a mutation in the first bromodomain of Bdf1 can cause splicing defect. 
In addition to all the previously discussed mutations, the silent mutations observed in 
some of these mutants might interfere with translational rates, despite failing to change 
the amino acid at a particular position. However, until further validation of these 
phenotypes is achieved, it is unclear what their role is. In conclusion, mutations in the 
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C-terminal phosphorylation region and the SEED domain of Bdf1, which belong to the 
region of Taf7 interaction (amino acids 500-686 in Bdf1), are so far the most likely 
candidates in defining a domain which might be important for pre-mRNA splicing.  
 
3.4 Discussion 
Bdf1 is a 686 amino acid protein with multiple functions in budding yeast. Aside from 
its role in transcription and chromatin remodeling through its interaction with SWR-C, 
it was initially described as a factor associated with chromatin which is required for 
sporulation [29, 30]. In addition, a separate function for Bdf1 was described in 
inhibiting the spreading of heterochromatin from subtelomeric regions into areas 
characterized by active gene expression, by competing with the Sir2 deacetylase on 
histone H4 tails [13, 31, 32]. Bdf1 and Bdf2 are homologues which resulted following 
the whole genome duplication event which took place in an ancestor of S. cerevisiae 
~100 million years ago. Despite sharing significant sequence homology, Bdf2 plays a 
more limited role in the cell. Bdf2 can interact with Taf7 and recruit RNA polymerase 
in the absence of Bdf1, but was not purified together with the SWR-C complex [15, 
33] and has equal preference in binding histone tails. Moreover, Bdf2 is not required 
for sporulation and does not appear to exhibit any other function aside from its 
involvement in transcription. This could be partially explained by the fact that Bdf1 is 
the more abundant cellular isoform among the two (~8100 copies/cell as opposed to 
~2930 copies/cell for Bdf2 [5]). Nevertheless, overexpression of Bdf2 in a bdf1∆ 
background did not rescue the over-accumulation of U3 precursor levels which are 
observed in this strain (data not shown), suggesting that it is likely unable to suppress 
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the splicing defect exhibited in bdf1Δ.  All these lines of evidence suggest that Bdf1 
plays multiple roles, only part of which are fulfilled by Bdf2.  
In this study, I followed up on a previous observation that bdf1∆ leads to a general 
splicing phenotype in S. cerevisiae, whereas bdf2∆ is aphenotypic. By applying the 
method described in Chapter two in a forward genetic manner, I have mapped residues 
within Bdf1 which when mutated lead to a bdf1∆ phenotype, measured an increase in 
the accumulation of U3 precursor. Although this approach was only applied on a small 
subset of mutants as part of a pilot test, I was able to identify several candidates, 
which suggest that the C-terminal tail of Bdf1 may be linked to its function in pre-
mRNA splicing. Even though these candidates await characterization by splicing 
sensitive microarrays, in the future this type of approach could be expanded to more 
precisely determine “hotspots” within the protein which are impacted when the 
splicing related function of Bdf1 is lost.   
Given that the Bdf1 gene is 2100 nucleotides long, and assuming that a mutation at 
each position would generate a viable mutant, one would require 2100 unique mutants 
to generate 1X coverage of this gene. In my current test, I can assume a median of ~5 
mutations/gene. Thus, screening of about 2000 mutants (about 5-6 384-well plates) 
would generate ~5X coverage of the Bdf1 ORF. Nevertheless, with an increased 
number of mutants comes the complicated task of assessing how important the 
mutated residues really are for Bdf1’s role in pre-mRNA splicing. In addition, since 
the mutazyme strategy relies on the number of PCR cycles for achieving the desired 
mutation rate, an increased number of PCR cycles will most likely lead to an 
oversampling of certain mutations or mutation combinations and to the under 
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sampling of others. If one assumes that one third of the mutations will fall within the 
wobble position of the codon and thus most likely lead to silent mutations, whereas 
some mutations will not change the charge on the native amino acid, the number of 
strains that would be required to capture all these mutants would increase 
significantly. Thus, an approach that would use a low mutation rate (1-3 
mutations/gene) combined with a number of strains which can be easily handled but 
would allow for 2-3X coverage of the Bdf1 gene would be a good starting 
compromise.  A low mutation rate would have the advantage of more unique 
mutations being sampled, together with a far simpler way of identifying the relevant 
residues. While some combinations of mutations will certainly be lethal (for example 
the two mutations in the active sites of the two bromodomains), most will still likely 
not impact a Bdf1 specific function, making this a good starting point for a larger 
screen. Nevertheless, the current test shows that a medium number of mutations can 
pinpoint important domains within the Bdf1 protein which are more likely to indicate 
a specific function. One could envision that in parallel with the mutagenesis approach 
that involves the entire Bdf1 ORF, smaller screens that are targeted towards specific 
domains could be easily employed, and would allow for a better characterization of 
definite Bdf1 regions. 
In order to identify unique residues in Bdf1 that might offer insights into its 
specialized role in splicing, it is important to examine these mutations in the context of 
Bdf1’s protein domains which undoubtedly underlie its modularity. Bdf1, as a member 
of the BET family [34] contains two N-terminal bromodomains and a C-terminal 
acidic tail. Within this C-terminal tail, it possesses a region of conservation with other 
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BET members known as a B2 box (see figure 3.3A), a NET domain (N-terminal ET 
domain) followed by a less conserved intervening sequence and a distal SEED 
domain. All of these domains are conserved with Bdf2 which is a member of the same 
protein family.  However, the residues within some of these domains are highly 
dissimilar and moreover, there are regions in Bdf1 which are absent from Bdf2 (see 
figure 3.3B). Therefore, when searching for mutations which confer specific Bdf1 
functions, the lack of conservation with Bdf2 and the high conservation with Bdf1 
homologues from other yeast species can be highly relevant. Given that negative 
strains which contain all the mutations in a candidate strain and lack only the ones 
which are important for Bdf1’s function in splicing are unlikely to be encountered, a 
better approach is to search for hotspots within the protein which are more likely to 
exhibit a splicing defect when mutagenized.  
The mutants identified in this screen which cause an upregulation in U3 snoRNA 
precursor levels higher than 2-fold map primarily to two regions of the Bdf1 protein –
the N-terminal coiled coil which lies upstream of the bromodomains and the C-
terminus past the second bromodomain. A single mutation of questionable importance 
maps to the first bromodomain. Only a couple of mutations in the candidate strains 
map to the N-terminal coiled coil - S24N in the K5 mutant and D96E in the K17 
mutant, whereas the M15 mutant displays all 3 mutations in the C-terminal region. It 
could be argued that the D96E mutation doesn’t cause a major change in the protein 
environment, since it exchanges a negatively charged amino acid with one of the same 
charge which is only slightly larger. Moreover, it occurs in a residue of Bdf1 which is 
not highly conserved. While no such argument can be made for S24N, the N-terminal 
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coiled coil appears to be more permissive to mutation than other Bdf1 domains. The 
evidence for this is that several of the mutations in the negative strains which do not 
lead to a significant upregulation of U3 precursor levels occur at a higher rate within 
this coiled coil region, and that these mutations are as likely to occur in very 
conserved residues (5/5 yeast species, e.g E41V in mutant D8) as in less conserved 
ones (G76D in mutant M13). In addition, the fact that the M15 mutant does not harbor 
any mutation in this domain but still significantly upregulates U3 precursor levels 
suggests that this is not the major domain responsible for Bdf1’s role in splicing. 
Four of the mutations in the confirmed candidates are located in the NET domain. This 
domain is conserved in all BET proteins (for example: human RING3, murine MCAP, 
Drosophila fsh (for review see [34, 35]) and is relatively well conserved between Bdf1 
and Bdf2, though not at the extent of the conservation seen at the level of the 
bromodomains. The NET domain has a helix-helix loop-extended beta sheet-helix (H-
H-L-E-H) structure, although in the case of Bdf1 the beta sheet is quite short. While 
the mutations I551V (in K5) and I555L (in K17), which occur in the second helix of 
this domain, are less likely to be linked to the splicing phenotype because they are in 
residues that are identical in Bdf1 and Bdf2, the H578Q mutation occurs in the second 
helix of the Net domain, but in a region where Bdf1 and Bdf2 are dissimilar. However, 
it is unclear if this mutation is necessary for the upregulation of U3 precursor levels 
since it occurs in a non-conserved residue.  
So far, a common denominator for the three mutants which mimic the bdf1Δ 
phenotype is that they lead to the modification of the very C-terminal end of the 
protein, usually past amino acid 600, either through the insertion of a premature 
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termination codon or through frameshift. This region is important because it 
encompasses the C-terminal phosphorylation domain (known as CPR, amino acids 
660-679) in Bdf1 as described by Sawa et al. [23] and also the terminal SEED domain. 
The SEED domain is enriched in negatively charged amino acids and serine residues 
and is believed to be a putative ATP binding motif. Moreover, the SEED domain is 
distinct in Bdf2. Therefore, this region is interesting threefold: 1) it falls within the 
region of interaction with Taf7 (amino acids 500-686); 2) it overlaps with an area of 
Bdf1 modification (phosphorylation) whose importance for Bdf1 function is unknown 
and 3) part of the CPR domain overlaps with a deletion in Bdf2, while the SEED 
sequence is highly conserved in both Bdf1 and Bdf2 homologues but not between 
Bdf1 and Bdf2. An attractive hypothesis which remains to be tested is that this 
terminal region may be sufficient to account for Bdf1’s role in pre-mRNA splicing. 
An easy test of this hypothesis would be to construct plasmid versions of the candidate 
strains which retain all other mutations, but for which the non-sense mutations or the 
frameshift are reversed, and to determine if the accumulation in U3 precursor levels 
still persists. 
While not a mutation hotspot which correlates with significant increases in U3 
precursor levels, the first bromodomain contains a mutation A208T in the coil between 
helix A and B in the K5 mutant. Moreover, the A1 mutant which causes 70% increase 
in U3 precursor levels compared to wild-type contains an A245D mutation in helix C 
of BD1. It will remain to be seen if mutations in this bromodomain are necessary or 
sufficient (in the case of the A1 mutant) to cause a splicing defect and if they correlate 
with any charge change in the binding pocket of the acetyl lysine. Since the 2-fold 
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increase in U3 precursor levels is somewhat arbitrary, a different assay, such as 
splicing sensitive microarrays will be required to fully characterize the mutations 
which are sufficient to cause splicing defects and test the magnitude of these defects.  
In contrast, the mutations in the negatives either cluster in the N-terminal coiled coil 
where they equally affect conserved or non-conserved residues, or predominantly 
occur in regions of lower Bdf1 conservation. Some of these mutations also occur in 
regions where Bdf1 and Bdf2 are highly conserved, where they may presumably 
impact the transcription function which is common to Bdf1 and Bdf2. Moreover they 
tend not to change the hydrophobicity or relative charge of the original residue, or can 
lead to premature stop codons in the last but one amino acid, which is likely too distal 
to affect Bdf1’s interaction with a target factor. While these guidelines are generally 
true, they cannot account for every amino acid change which occurs within these 
mutants. As before, in the case of the confirmed candidates, additional proof will be 
required to definitively declare that a specific residue is unimportant for Bdf1’s role in 
splicing. Since a combination of mutations can lead to distinct phenotypic outcomes, 
our approach is more likely to pinpoint protein domains which are important for this 
function, rather than ones that are not. Nevertheless, at present, the C-terminal region 
encompassing the CPR and the SEED domain appears the most likely candidate for 
connecting Bdf1’s transcription role with splicing. In the future, it will be important to 
further address the mechanism behind Bdf1’s role in splicing. To this end, identifying 
the interactions which are missing in a Bdf1 mutant which causes a global splicing 
defect versus a wild-type, will represent a first step in defining more targeted 
interaction domains in Bdf1. 
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CHAPTER 4 
 
MUD1 AUTOREGULATES ITS EXPRESSION BY A DIFFERENT MECHANISM 
THAN ITS HUMAN HOMOLOGUE U1A 
 
4.1 Introduction 
The spliceosome is a massive macromolecular machine responsible for the excision of 
introns and ligation of exons from eukaryotic precursor mRNA substrates. At twice 
the size of the ribosome, this complex consists of the 5 small nuclear RNAs (snRNAs) 
U1, U2, U4, U5 and U6 and between 150 and 300 proteins [1]. Substrate recognition 
and catalysis of the two transesterification reactions central to pre-mRNA splicing are 
the result of the careful interplay between the snRNAs which are packaged with core 
spliceosomal proteins in snRNP particles and the numerous non-snRNP proteins. 
The dynamics of the spliceosome are extensive. In order for a single transcript to be 
processed, the splicing machinery must gradually assemble onto the substrate. The 
first snRNP to recognize the substrate through base pairing interactions with the 5’ 
splice site is U1 which leads to the formation of the commitment complex, followed 
by the ATP-dependent recognition of the branch point adenosine by U2snRNP (see 
figure 1.1 Introduction). Next, the tri-snRNP consisting of U4, U5 and U6 snRNPs 
assembles and leads to rearrangements which will allow for the formation of the 
catalytically active U2-U6snRNP core [2, 3] and lead to the exclusion and recycling of 
the U1 and U4 snRNPs. Subsequent reorganization of the catalytically active 
spliceosome is required for the transitioning through the two transesterification 
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reactions as well as for the final recycling of the spliceosomal subunits. Considering 
this requirement for very swift and precise dynamics, it is crucial that each step of the 
reaction if very carefully controlled. To this end, a breadth of RNA-dependent 
ATPases and helicases are recruited to ensure that the numerous rearrangements lead 
to the correct processing of the pre-mRNA substrate. 
Given the absolute need for very precise regulation, it is not surprising that this 
regulation extends to the level of the individual spliceosomal subunits. Such an 
example is the U1snRNP protein U1A in higher systems, which binds loop B on 
U1snRNA. In mammals, U1A has been shown to down-regulate its expression 
through a polyadenlylation inhibition (PIE) element located in its 3’UTR (see figure 
4.1) [4].  
 
Figure 4.1: Comparison of the U1A 3'UTR sequence with the U1snRNA binding 
hairpin which is recognized by U1A (adapted from Oubridge et.al [13]) 
 
This bipartite element contains one box that is identical to the binding site of U1A on 
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loop B (Box2) of the U1snRNP and a second of high sequence similarity. The N-
terminal RNA recognition motif (RRM) of U1A binds the PIE element [5] and inhibits 
polyadenylation through a direct interaction with the C-terminal 20 residues of the 
mammalian, but not yeast, polyA polymerase [6,7]. Furthermore, U1A contacts the 
PIE element upon dimerization through residues 102-115 [7-9] and it was shown that 
the binding surface has to be accessible on the same side of the RNA. Evidence from 
several NMR [10,11] and X-ray crystallography studies [12,13] supports this model, 
by which U1A binding to the PIE element induces a conformational fit which favors 
the formation of a dimerization surface. 
Although the mechanism through which U1A fine-tunes its expression has been 
thoroughly investigated for higher systems, such a mechanism has not yet been 
reported in budding yeast. The yeast homologue, Mud1 (Mutant U1 Die) was 
discovered through an enhancer screen for mutants which exhibited synthetic lethal 
phenotypes in the absence of a functional U1snRNA [14]. Mud1 is a non-essential 
protein which was shown to bind U1snRNA and is hypothesized to participate in the 
proper folding of this RNA. Mud1, like its mammalian counterpart U1A, has 2 RRMs 
and shows high conservation at the protein level with its homologue, especially at the 
level of the C-terminal RRM (36%  identity, 64% similarity). While the deletion of 
Mud1 does not affect cellular growth rate, the mud1-1 mutant which truncates the 
protein at amino acid 84 leads to faster migrating commitment complexes and 
decreases their formation, as well as inhibits the splicing of inefficiently spliced 
reporters. Since the mud1-1truncation is in the middle of the first RRM, the mud1-1 
mutation is thought to lead to little or no functional Mud1 protein. 
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Interestingly, while the secondary structure of U1 snRNA is conserved between yeast 
and higher systems, at the sequence level the differences are more pronounced. Thus, 
in S. cerevisiae, U1snRNA contains a fungal domain which is conserved among yeast 
species (Figure 4.2) [15].  
 
Figure 4.2: Schematic of the binding of U1A to the mammalian, versus the yeast U1 
snRNA  
 
Moreover, there is a lack of conservation between the yeast and mammalian loop B, 
the corresponding yeast counterpart having a longer and more varied stem-loop 
structure. By using in vivo dimethyl sulfate (DMS) footprinting, Tang et al. [16], 
showed that the N-terminal RRM of Mud1 binds loop IIIC of the yeast U1snRNP. 
Furthermore, they showed that deletion of the Mud1 C-terminal RRM which has no 
known function in higher systems impairs splicing in a CUP1 reporter system. This 
suggests that in yeast, the conserved C-terminal domain might play an independent 
role in splicing which is supported by evidence showing that the mammalian C-
terminal RRM cannot complement this function. Therefore, while the binding of U1A 
and Mud1 to U1snRNP through the N-terminal RRM is a conserved process, the exact 
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sequences which are used differ between organisms. Moreover, the C-terminal domain 
appears to have an additional function in yeast. 
Here I report that mutations in the cleavage and polyadenylation factors cft2-ts and 
yth1-ts lead to misregulation of Mud1 levels in Saccharomyces cerevisiae, suggesting 
a defect in the 3’end processing and decay of these species. This is not a general 
phenotype caused by mutations in the cleavage and polyadenylation machinery, since 
mutations in another 3’end cleavage and polyadenylation factor – fip1-ts have no 
effect on Mud1 levels. In addition, I show that overexpression of a cDNA version of 
Mud1 causes down-regulation of endogenous Mud1 levels. However, upon 
replacement of the endogenous 3'UTR, no misregulation of Mud1 levels is observed, 
suggesting that the 3’UTR is not sufficient for this regulation. Therefore, unlike in 
higher systems, the mechanisms of Mud1 autoregulation cannot be limited to an 
element in its 3'UTR. Since Mud1 is an intron containing gene, and there is ample 
evidence of coupling between CPSF and splicing of the last intron [17-24], I 
considered that Mud1 might represent a good model to study this coupling in budding 
yeast. Below, I discuss my findings in connection with new data from Madhura 
Raghavan who is investigating this regulation further.  
 
 
 
 
 
 126 
4.2 Materials and Methods 
4.2.1 Plasmids and strains 
Temperature sensitive alleles from the Hieter collection [25], the brr5-1 mutant [26], 
the Tap-tagged version of Mud1 [27] and the wild type strain yBY4741 [28] were 
used. Plasmids containing different versions of Mud1 were cloned into pRS416 (CEN) 
or pRS426 (2 micron) URA marked vectors using standard cloning procedures. The 
cDNA version of Mud1 contains ~200 bp in the 5'UTR of the gene and ~600bp of the 
3'UTR, and was obtained by stitching PCR fragments to omit the intron. Unless 
otherwise specified, the strains lacking a plasmid were grown in rich YPD media 
supplemented with 2% glucose [29] at permissive temperature (25 or 30°C). The 
strains harboring plasmids were grown in SD-Ura media at 25°C and compared to 
empty vector controls grown under the same conditions.  
 
4.2.2 RNA extraction, cDNA synthesis and qPCR 
RNA extraction, DNase treatment and cDNA synthesis and qPCR were performed as 
previously described in chapter 3. The primers used for detecting Mud1 total and 
Mud1 precursor levels as well as endogenous Mud1 (TAP) levels are shown in Table 
4.1 
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Table 4.1: Forward and reverse primer sequences used for amplifying the target 
gene in qPCR 
 
The list of forward and reverse primers used: 
 
Target Forward primer Reverse primer 
Mud1 total 
AAT AAG ACG CCT GAA GCA TAA 
GCT 
CTA TCA ATC TCA GCC TCC TCT ACC 
TT 
Mud1 precursor AAAAAGCTGCTATCAACAAAAGACG AAGATTTAAGGAAACGTAAATTAC 
Faa1 total 
TCT GCC CTA TGC TTA TTG GTT 
ACG 
TAA CAC AAC CTG TTA GGT CAC CAG 
C 
Mud1-TAP  TCGTAACCTAGCTTTCGTGGAATAC CTGCTGAGACGGCTATGAAATTCTT 
 
 
4.3  Results 
4.3.1 Mud1 levels are misregulated in 3’end processing mutants 
In the genome-wide screen described in chapter 2, I identified cft2-ts and yth1-ts, two 
components of the cleavage and polyadenylation CPSF complex which cause targeted 
splicing defects. Interestingly, upon genome-wide characterization of these mutants by 
means of splicing sensitive microarrays, Mud1 was the only transcript to exhibit a 
very pronounced misregulation in transcript levels, where all measured species (total, 
precursor or mature) displayed an 8-16 fold increase (Figure 4.3A). Even though 
increases in Mud1 levels are shown in figure 4.3A at the non-permissive temperature 
of 37°C, this misregulation is also apparent at the permissive temperature of 25°C or 
under cold shock (Figure 4.3B). These phenotypes do not correlate with the robustness 
of strain growth. Figure 2.14 shows that while cft2-ts is sick at 16°C, the growth of 
yth1-ts is not significantly different from wild-type. 
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Figure 4.3:  Mutations in cleavage and polyadenlyation factors cause Mud1 
misregulation 
A. Splicing sensitive microarrays for the cleavage and polyadenylation factor 
mutants yth1-ts, cft2-ts, ysh1-ts and brr5-ts and blow-up of the Mud1 levels 
shown below each array. Each of the arrays was clustered independently. The 
red arrows indicate the position of Mud1 on each of the arrays. 
B. Blow-up of array data for cleavage and polyadenlyation mutants at either the 
permissive or non-permissive temperatures 
C. q(RT)PCR assessing the expression levels of the total Mud1 transcript relative 
to a wild-type control. All strains were grown at 25°C. The values are reported 
on a log2 scale. 
 129 
 
Yth1-ts is essential in yeast and is the homologue of mammalian CPSF30 [30] to 
which it is 40% identical. Mutants in different regions of Yth1 have been shown to be 
defective in both cleavage [31] and polyadenylation. Yth1 physically interacts with 
other members of CPSF such as Ysh1 and Fip1 through its C-terminal domain [31, 32] 
and binds pre-mRNA close to the cleavage site. Similarly, Cft2 is the homologue of 
mammalian CPSF100 and binds to uncleaved substrates in an ATP-dependent fashion 
[33]. Mutations in Cft2 lead to the inhibition of both the cleavage and polyadenylation 
reactions [34, 35]. Cft2 is generally involved in providing interaction surfaces within 
the CPSF complex and it also interacts with the CTD of RNA polymerase II. 
Moreover, in yeast, deletion of the RNAPII CTD was shown to lead to a decrease in 
cleavage efficiency [36, 37].  
Since I observed misregulation in Mud1 levels in two CPSF factors, I wanted to 
determine if this was a general phenotype observed upon mutation of the cleavage and 
polyadenylation machinery.  Thus, I chose to monitor Mud1 expression levels in other 
cleavage and polyadenylation mutants: fip1-ts and ysh1-ts/brr5-1. Fip1 functions as an 
anchor between the CPSF complex (through Yth1) and the polyA polymerase (Pap1) 
[38, 39] and controls polyadenylation. In contrast, ysh1-ts and brr5-1 are mutants in 
the same CPSF factor, the yeast homologue of mammalian CPSF73. Ysh1 is the most 
conserved factor of the CPSF complex at 53% identity with its bovine homologue [40] 
and it is still debated if it represents the endonuclease within the complex [41]. The 
ysh1-ts allele used in this study was created by the Hieter lab and is lethal at 34°C. 
brr5-1 was first discovered as a cold sensitive splicing mutant which is required for 
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3'end processing [42] and fails to grow at 16°C (see Figure 2.14). 
Mud1 levels are indeed up-regulated in the ysh1-ts and brr5-1 mutants at the 
permissive temperature (25°C for ysh1-ts and 30°C for brr5-1) as shown in figure 
4.3A. Similar to the phenotypes seen for cft2-ts and yth1-tsat 37°C, the Mud1 
transcript is the only one which displays such a profound misregulation and clusters 
independently at the bottom of the array. In addition, brr5-1 displays a ~16-fold 
increase in Mud1 levels at the non-permissive temperature of 16°C, whereas the ysh1-
tsallele shows an increase of only about 2-fold at 37°C. Nevertheless, in contrast to the 
three CPSF mutants I analyzed, fip1-ts doesn't cause any change in total or mature 
Mud1 transcript levels. The data suggests that while not all mutations in components 
of the cleavage and polyadenylation machinery impact Mud1 transcript levels, 
mutations in CPSF components in particular might cause misregulation of Mud1 
expression. However, M. Raghavan has shown that a mutation in pta1-ts, which is the 
fourth factor of CFII together with Cft1, Cft2 and Ysh1 [43], does not cause 
misregulation of Mud1 levels (data not shown). While it cannot be excluded that the 
phenotypes are allele specific, this indicates that specific mutations in cleavage and 
polyadenylation factors impact Mud1 levels.  
It is important to note that the 8-16 fold increase in Mud1 levels reported in the cft2-ts, 
yth1-ts, ysh1-ts or brr5-1 strains partially reflects the upper limit of detection for the 
microarrays. To get a more accurate determination of the change in transcript levels 
and to verify these results, I used small scale quantitative real-time PCR (qPCR). 
Mud1 total levels were increased 8-10 fold in the cft2-ts, yth1-ts and brr5-1 
backgrounds (Figure 4.3C). In my hands, ysh1-ts did not show more than a 50% 
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increase in total levels. However, M. Raghavan reported at least a 3-fold increase in 
Mud1 total levels for the same experiment. As expected, fip1-ts did not cause any 
misregulation in Mud1 expression. 
 
4.3.2  Mud1 overexpression regulates the endogenous copy 
Since the mammalian homologue of Mud1, U1A, is capable of autoregulating its 
expression, I asked whether expression of Mud1 from an ectopic location could 
influence the expression of Mud1 in its chromosomal context. To test this, I 
constructed a cDNA version of Mud1 on a high copy vector and expressed it in a 
Mud1-Tap strain. The Mud1-Tap strain expresses a Tap tagged version of Mud1 and 
contains the endogenous Mud1 5'UTR and the Mud1 intron, but has an ADH1 3'UTR. 
Overexpression of an exogenous Mud1 cDNA within this strain increased the total 
Mud1 levels above 35-fold (Figure 4.4) and caused a ~2-fold downregulation of the 
endogenous Mud1 precursor and total levels (measured as Mud1-Tap). Curiously, the 
splicing efficiency of the endogenous transcript increased by ~50% (not shown). In 
addition, M. Raghavan's data indicates that Mud1 overexpression also leads to a 2-fold 
decrease in Mud1-Tap tagged protein. Taken together, these results support a model in 
which an excess of Mud1 protein is capable of decreasing the endogenous production 
of Mud1, so that the Mud1 homeostasis is maintained.   
 132 
 
Figure 4.4: Mud1 overexpression down-regulates the chromosomal Mud1 copy  
 
Mud1 total (left) and Mud1 precursor and Mud1 (TAP) endogenous levels measured 
by qPCR. The values are normalized to an empty vector control and presented in log2 
space. A representative experiment is shown and the error bars indicate standard 
deviation of technical replicates  
 
 
4.3.3  The Mud1 3’UTR is not sufficient for regulation  
To test the similarity between U1A’s and Mud1’s mechanisms of autoregulation, I 
asked if Mud1 levels were controlled through a negative regulatory element in the 
Mud1 3'UTR. Unlike in the case of the human U1A, I was not able to detect a 
sequence element in the Mud1 3'UTR reminiscent of the U1snRNA loop sequence 
which Mud1 binds as part of the U1snRNP. In addition, the Mud1-Tap endogenous 
copy was repressed upon Mud1 overexpression, even though it lacked its native 
3'UTR. This suggests that the mechanism of Mud1 regulation might be independent of 
its 3'UTR. To test this prediction, I analyzed Mud1 expression levels by qPCR in the 
Mud1-Tap strain. In this strain the endogenous Mud1 3'UTR is replaced with the 
ADH1 3'UTR, whereas the endogenous Mud1 3'UTR is shifted about 3kb downstream 
of the STOP codon and thus is believed not to be functional. If the 3'UTR is indeed 
sufficient for regulation, one would expect to see the same misregulation in Mud1 
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levels in the Mud1-Tap strain as in the 3'end mutants. Mud1 total levels were 
unchanged from the wild-type control in the Mud1-Tap background (Figure 4.5). 
Moreover, a Blast analysis identified no similarity between the Mud1 and Adh1 
3'UTRs and M. Raghavan's data suggests that the Tap-tag does not interfere with 
Mud1 processing (data not shown). In conclusion, the endogenous 3'UTR does not 
appear to be important for Mud1 regulation. 
 
Figure 4.5: The absence of the native Mud1 3’UTR does not misregulate Mud1 
levels 
Mud1 total levels in log 2 space as measured by qPCR. The Mud1ADH1 3’UTR 
levels are normalized to the WT (yBY4741) strain. 
 
 
4.3  Discussion 
The model through which U1A inhibits its own expression is one of the best 
characterized models of regulations in mammals. Here I present evidence that Mud1, 
the yeast homologue of U1A is also subject to autoregulation, though the mechanism 
through which this happens is currently unknown. My first observation, that Mud1 
levels are misregulated in 3'end processing mutants (Figure 4.3) suggested that Mud1 
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might use a similar mechanism to its human counterpart. However, it soon became 
apparent that Mud1 lacks sequences in its 3'UTR that resemble the binding sequence 
Mud1 binds on U1snRNA, as is the case with U1A. Moreover, a chromosomal version 
of Mud1-Tap which has the 3'UTR replaced with an ADH1 3'UTR can be 
downregulated at the RNA and protein level upon Mud1 overexpression (Figure 4.4). 
Since the two 3’UTR sequences are very dissimilar from one another, this suggested 
that the negative regulatory sequence lies outside the 3'UTR. Lastly, the Mud1-Tap 
strain by itself did not show any increase in Mud1 total levels (figure 4.5), as did the 
cft2-ts and yth1-ts mutants, further indicating that the sought negative regulatory 
element is not in this region. 
Since Mud1 does not appear to share the same regulatory mechanism with U1A, I 
considered an alternative model in which Mud1 might be a sensitized transcript which 
would allow us to study splicing-3'end connections. There is plentiful evidence about 
the interplay between splicing of the last intron and 3'end processing. Early studies in 
mammalian systems showed that the presence of an upstream intron with a functional 
3' splice site enhanced polyadenylation [22] and conversely, mutations in the 
polyadenylation signals inhibited splicing of the upstream intron [23]. More recently, 
several physical interactions between spliceosomal subunits and the cleavage and 
polyadenylation machinery have been described. Thus, the UAF65 physically interacts 
with CFmI59 [21] to promote cleavage and polyadenylation in vitro, while the 
presence of the wild-type but not mutated polyadenylation signal stimulates U2AF65 
recruitment to the polypyrimidine tract of the upstream intron [24].  Furthermore, the 
25kDa subunit of CFI coimmunoprecipitates with U1 snRNP protein 70K [17], 
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whereas the N-terminus of U1A interacts with the 160kDa subunit of CPSF and 
stabilizes its interaction with the polyA signal sequence in vitro [20]. Also, data from 
the Keller lab indicates a direct interaction between U2snRNP and CPSF in mammals 
[19]. Finally, I have identified several mutations in cleavage and polyadenylation 
components in yeast which cause targeted splicing defects (Chapter 2), while the 
Keller lab reported a ysh1-12 allele defective in splicing [44]. All these lines of 
evidence underline the extensive coupling between splicing and 3'end processing. 
Mud1 is a very good substrate to study this coupling because it is an intron containing 
gene with a suboptimal intron. Within the 89bp Mud1 intron, the branch point is 
unusually located in the middle of this sequence. Genome-wide ChIP-chip data [45] 
also indicates that U2 is suboptimally recruited to this branchpoint, which given the 
coupling between splicing and CPSF, would make Mud1 intron more sensitive to any 
variation in CPSF recruitment. One could easily imagine that the absence of a 
functional CPSF which has mutant versions of Cft2, Yth1 or Ysh1 would inhibit 
recruitment of U2snNRP. In turn, spliceosome assembly would be hindered, since the 
U1 snRNP recruited at the 5' splice site would have no U2 to interact with. The 
Vagner et al. study [24], showed that at least in mammals, U1 snRNP is not involved 
in the recruitment of U2AF to the polypyrimidine tract. In addition, two studies have 
shown that in mammalian systems, U1snRNP depletion can cause premature cleavage 
and polyadenylationin introns [46, 47]. These studies work under the hypothesis that 
U1 can base pair to cryptic sites within the genome and protect the transcript from 
usage of cryptic polyadenylation signals (PAS). However, polyA site recognition is 
inhibited by the presence of a 5'splice site [48], and it is thought this inhibition occurs 
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through an interaction between U1 70K and PAP [49]. Thus, an alternative hypothesis 
is that if a functional spliceosome can be assembled, then the U1 to U2 "hand-off" can 
protect the intron from premature cleavage and polyadenylation. If early spliceosome 
assembly cannot occur, then the cleavage and polyadenylation machinery can act upon 
the substrate and cause cleavage at cryptic sites. This model is in agreement with the 
toolbox model of the RNA polymerase II CTD which interacts with U1 and CPSF [50, 
51]. The Mud1 transcript was a particularly attractive model to test this hypothesis, 
since PolyA-Seq data [52] suggests that there are several sites in Mud1 intron which 
can lead to premature termination and thus function to down-regulate its expression. 
Nevertheless, this model was hindered by two observations: 1) that the 3'UTR is not 
required for Mud1 regulation and 2) that the intron is not necessary either. M. 
Raghavan has shown that a Mud1 intronless version containing the native 3'UTR 
expressed at 1-2 copies/cell in a mud1Δ strain causes no misregulation of Mud1 levels, 
while the same plasmid in a mud1Δ yth1-ts background can entirely recapitulate the 
misregulation seen in the yth1-ts or cft2-ts background. This suggests that the intronic 
sequence does not contain the element required for Mud1 repression. 
If the Mud1 element required for its regulation is not present in the 3'UTR or in the 
intron where is it located? The creation of an intronless Mud1 ADH1 3'UTR that can 
still recapitulate the misregulation in the mud1Δ yth1-ts background will still be 
required and would suggest that the regulatory element is contained fully within the 
remainder of the Mud1 sequence, including the 5’UTR. Moreover, given the polyA-
seq data which suggests that cleavage and polyadenylation occurs within the intron, at 
a time perhaps prior to exon 2 synthesis, it is likely that exon 2 does not contain the 
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regulatory element. Nevertheless, the way this regulation is achieved and its interplay 
with CPSF remain to be discovered. 
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CHAPTER 5 
 
FUTURE DIRECTIONS 
 
5.1 Mapping spliceosome assembly genome-wide in a wild type, bdf1Δ 
and bdf2Δ strain 
Loss of Bdf1 but not of its homologue Bdf2 leads to a global misregulation in pre-
mRNA splicing. Both Bdf1 and Bdf2 are capable of interacting with Taf7 and 
recruiting RNA polymerase II, and it was shown that in the absence of Bdf1, Bdf2 can 
be recruited to some Bdf1 specific promoters and substitute for its transcriptional 
function. Thus, my working hypothesis has been that, while both Bdf1 and Bdf2 can 
interchangeably function in transcription, only Bdf1 maintains a role in pre-mRNA 
splicing. Given that only 5% of yeast genes contain an intron, loss of Bdf1 would lead 
to a global splicing defect, which would not cause lethality if intron-containing genes 
could still be inefficiently spliced. 
Consistent with this hypothesis, only bdf1Δ decreased the recruitment of the first 
spliceosomal factor to recognize the substrate, U1 snRNP, for several intron-
containing genes in a small scale ChIP-qPCR experiment. Intriguingly, the same 2-
fold decrease that was observed for U1 snRNP, was also observed for RNA 
polymerase II levels. However, one cannot simply dismiss this as purely a 
transcription defect, since if RNA polymerase recruitment is halved, one would expect 
a two-fold decrease in transcription, but no a priori defect in splicing, even if the 
spliceosome was recruited at half its normal levels. A decrease in transcription on a 
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splicing sensitive microarray would appear as a concomitant decrease in the total, 
precursor and mature levels when compared to a wild-type strain. This is not 
consistent with what I observed on a bdf1Δ array in which precursor levels were 
significantly upregulated, suggesting a secondary splicing defect. 
Since so far I have only tested this hypothesis on a small subset of genes, it would be 
interesting to expand this study to map spliceosome recruitment genome-wide. Such 
an analysis would allow me to address several questions: (1) Is the decrease in U1 
recruitment observed in bdf1Δ a global phenotype that is present on all intron-
containing genes or does it affect specific classes of genes? (2) Is only the recruitment 
of U1 impacted, or are the other snRNAs less efficiently recruited as well? (3) Is the 
correlation between U1 and RNA polymerase II recruitment a global phenotype and if 
not, what types of genes is it associated with? (4) Is the defect in recruitment simply a 
quantitative feature or can delays in recruitment be observed in the body of the genes? 
(5) Since Bdf1 is actively recruited at the level of the +1 and +2 nucleosomes, are 
these nucleosomes more stable in a bdf1Δ and does that impact RNA polymerase II 
profiles? (6) Are any of the observed changes in a bdf1Δ strain correlated with 
expression levels, and exonic or intronic features? These and many other questions 
could be addressed by a ChIP-Seq study which globally maps RNA polymerase and 
nucleosome occupancy together with snRNP recruitment in a wild-type strain in 
comparison with a bdf1Δ and a bdf2Δ strain. 
To this end, I have generated several strains in which RNA polymerase or 
spliceosomal proteins that are stably bound to U1, U2 or U5 snRNPs are TAP-tagged 
in a background that is either wild-type, bdf1Δ or bdf2Δ. I have tested these strains to 
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ensure they match the bdf1Δ or bdf2Δ parent phenotypes, including the presence or 
absence of an increase in U3 snoRNA reporter levels. Unfortunately, the first ChIP-
Seq dataset that would start to address these questions did not have a high-enough 
resolution at the level of mapping snRNP recruitment and will have to be repeated 
with more input material. Nevertheless, the strains and methods are currently in place 
to monitor global spliceosome patterns in these backgrounds. 
 
5.2 Identifying and characterizing Bdf1 interactors     
Mutagenesis of Bdf1 coupled with a forward-genetic screen for mutants that mimic 
bdf1Δ phenotypes has generated a subset of mutants which map to the C-terminal end 
of Bdf1. Given the difficulty in precisely filtering out mutations which do not impact 
the splicing phenotype, one would ideally wish to map hotspots within the protein 
which are consistently mutated in true candidates. Expanding the number of mutants 
which are screened would broaden the number of mutations and better aid in mapping 
residues which are truly important for the splicing function of Bdf1. 
Nevertheless, despite the difficulty in assigning function to specific residues, and the 
complication which arises when combinations of mutations are present in a single 
strain, mutations which fall in highly conserved Bdf1 residues which are absent from 
Bdf2 can be highly relevant for indicating a Bdf1 specific function.  Once a domain or 
residues have been narrowed down, a first step would be to re-confirm the splicing 
phenotype though an alternative method such as splicing sensitive microarrays, or by 
testing the splicing of several intron containing genes which are impacted in the bdf1Δ 
array with small scale qPCR. Next, one can use these mutants to address the important 
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question of which interactions are disrupted in a Bdf1 mutant that mimics bdf1Δ. 
Using a method such as SILAC, the interactors of Bdf1 and its mutant can be 
comparatively mapped, to the level of changes in their post-translational status.  
Bdf1 displays several physical interactions with histone H4 (Hhf1, Hhf2), TAFs, 
SWR-C components (Swr1, Htz1) and Bdf2 (BioGRID). While none of its genetic or 
primary physical interactions involve splicing components, Prp9 (through Skp1), 
Prp43 (through Taf6, Cka2 or Htz1), Prp19 (through Swr1 and Ies1), Npl3 (through 
Hhf2, Spt16) or Prp31 and Cwc2 (through Rvb1) are just some of the secondary 
interactions which could link Bdf1 to its role in splicing. More importantly, these 
interactions are not shared with Bdf2. Interestingly, aside from Prp9 which 
corresponds to the mammalian U2 factor SF3a, most of these factors are involved in 
the later stages of spliceosome assembly together with the U4/U6/U5 snRNP or in 
spliceosome recycling (Prp43), and it will be interesting to see how they reconcile 
with the early defect in U1 recruitment. Identifying specific interactions which are 
disrupted in the Bdf1 mutants would aid in narrowing down this list of factors and 
shed more light on the mechanism behind Bdf1's role in splicing. Once such an 
interactor is identified, more specific interaction domains and its mode of action can 
be thoroughly examined. 
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APPENDIX  
 
PRE5, A PROTEASOMAL SUBUNIT INVOLVED IN PRE-mRNA SPLICING?  
 
 
A.1 Introduction 
 
The yeast proteasome is a large 2.5MDa multiprotein machine involved in the 
degradation of poly-ubiquitylated protein substrates. The 26S proteasome consists of a 
20S barrel-shaped core particle and two 19S regulatory subunits. Within the 20S core, 
there are 14 subunits – 7 alpha and 7 beta subunits which make up the 2 inner (β) and 
2 outer (α) rings [1,2]. All subunits except for one alpha subunit (Pre9) are essential in 
Saccharomyces cerevisiae. For a targeted protein to be degraded by the proteasome, it 
needs to be first unfolded by the ATPase subunits within the 19S regulatory particle 
and then fed through the 20S barrel towards the β subunits which possess catalytic 
activity. 
 
Figure A.1: The yeast 20S proteasome (adapted from [3] and [1]) 
 
Pre5 is the alpha 6 subunit of the yeast proteasome, a 234 amino acid protein whose 
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function is unknown [4]. It has conserved domains which are characteristic of the α-
type proteasome subunits and is homologous to the Drosophila PROS35, human C2 
and Arabidopsis PMS30 proteins. Little more is known about Pre5, such as that its 
repression leads to abnormal mitochondrial morphology [5] and that a reduction in 
Pre5 levels causes telomere shortening [6]. 
Interestingly, recent studies have uncovered a role for ubiquitin in pre-mRNA splicing 
[7]. Thus, an in vitro study has shown that mutant alleles of ubiquitin, as well as 
treatment with ubistatin, promotes disassembly of the U4/U6.U5 tri-snRNP complex 
and inhibits splicing. Tri-snRNP stability is dependent on the ubiquitination status of 
Prp8, a protein which is central to spliceosome activation and a member of the triple 
snRNP. The current hypothesis beyond this model is that a conformational shift of 
Prp8 which itself has a Jab1/MPN ubiquitin-interacting domain [8, 9] regulates the 
unwinding of the tri-snRNP, thus timing the transitions between the different steps of 
spliceosome rearrangements. Moreover, Prp19, a member of the NineTeen complex 
which stabilizes the association of U5 and U6 snRNPs with the activated spliceosome 
is itself a U-box E3 ubiquitin ligase [10, 11]. Investigation of Prp19 targets is currently 
underway, but the first one – Prp3, which is a component of the U4 snRNP – has been 
identified [12]. Prp19 modifies Prp3 with non-proteolytic K63-linked ubiquitin chains 
and increases its affinity for Prp8. Moreover, asides from studies in S. cerevisiae, two 
studies in S pombe [13, 14] identified that the mutation or deletion of Hub1, which 
also encodes a ubiquitin-like protein and interacts with the spliceosomal factor Snu66 
inhibits pre-mRNA splicing. Furthermore, it was shown that depletion of the human 
orthologue of Prp19, SNEV [15], impairs splicing in nuclear extracts. SNEV is also a 
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U3-box ubiquitin ligase [16] which, like Prp19, was shown to physically associate 
with the β7 subunit of the proteasome, although the purpose for this is currently 
unknown. Lastly, the mouse Prp19 was also shown to interact with SUG1, a 
regulatory subunit of the 26S proteasome [17]. Although the role of ubiquitin in 
regulating spliceosome dynamics is becoming clearer, the significance of the physical 
interactions between Prp19 and proteasome subunits and its importance in promoting 
degradation or in a different context remains to be addressed. 
Pre5 emerged as a candidate in my initial genome-wide screen for factors which 
impact pre-mRNA splicing. Microarray analysis showed that the pre5-ts allele [18] 
leads to a global inhibition of splicing, a novel phenotype so far unreported. While this 
phenotype does not appear to be an indirect effect caused by the altered expression of 
a splicing factor, it could arguably be linked to an indirect change in the protein levels 
of such a factor. Nevertheless, the expression of most genes in pre5-ts is similar to 
their expression in other proteasome mutants – pre1-ts and pre10-ts, as well as 
published datasets. However, these other mutants do not exhibit any splicing defects, 
suggesting that any putative role in splicing is specific to pre5-ts.    
 
A.2 Results and discussion 
In the genome-wide screen presented in chapter 2, pre5-ts caused an 8-fold 
upregulation in U3 precursor levels (Figure 2A), suggesting that it may play a role in 
pre-mRNA splicing. This upregulation was particular to the pre5-ts mutant, since none 
of the other proteasome mutants, either in the core or in the 19S regulatory subunit, 
showed this effect. To investigate this phenotype further, I employed splicing sensitive 
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microarrays to study the pre5-ts mutant and two other core proteasome mutants in the 
library: pre1-ts and pre10-ts. Pre1 is the β4 proteasome subunit and has an inferred 
endopeptidase activator activity [19], whereas Pre10 is the α7 subunit and was shown 
to bind RNA [20]. In our splicing sensitive microarrays, true splicing mutants like 
snt309∆ are characterized by an increase in precursor levels for most intron containing 
genes, as well as a lack of change or a slight decrease in the total and mature levels. 
Also, since our microarrays are always comparing the mutant version to a wild-type 
version, all changes are measured relative to the wild-type.  
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Figure A.2: pre5-ts impacts splicing genome wide 
 
A. The impact of proteasome mutants on U3 precursor levels. The data is shown 
on a log2 scale. The core proteasome mutants are colored in red, whereas the 
mutants in the 19S regulatory subunit are shown in blue. 
B. Growth phenotypes for the proteasome mutants under different temperature 
conditions 
C. Splicing sensitive microarrays in the pre5-ts background at permissive (25°C) 
or restrictive temperature. The pre5-ts datasets are clustered individually, 
whereas the snt309∆ mutant is ordered the same way as the data in the pre5-ts 
25°C mutant. 
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D. Microarrays for the pre1-ts and pre10-ts strains, clustered independently. The 
pre10-ts strain at 37°C shows a significant downregulation of ribosomal 
protein genes (right). 
 
 
The pre5-ts allele causes misregulation in precursor levels for most intron containing 
genes (figure 2C), displaying a phenotype very similar to the bona-fide splicing 
mutant snt309Δ. Curiously, this phenotype was more pronounced in the pre5-ts allele 
at the permissive temperature of 25°C, rather than after a 15 minute shift to the non-
permissive temperature of 37°C. Conversely, the two other proteasome mutants didn’t 
impact pre-mRNA splicing at all (figure 2D) – either at the permissive or the non-
permissive temperatures, which is consistent with the screen results (figure 2A). Of 
note is that the pre10-ts allele leads to a significant global decrease in the expression 
of ribosomal protein genes (RPGs) at 37°C, which is consistent with a role for the 
proteasome in controlling RPG expression levels [21, 22]. The expression of RPGs 
was previously observed to be decreased upon proteasome inhibition and in the 
presence of proteasome mutants, which correlated with a decrease in the recruitment 
of proteasome components and RNA polymerase II on these genes. 
Since I was intrigued that pre5-ts would show a more pronounced splicing defect at 
25°C rather that at the non-permissive temperature [18], I decided to examine the 
growth phenotypes of the proteasome mutants I was investigating. As seen in figure 
2B, the pre5-ts allele did not show any growth defect at the non-permissive 
temperature of 37°C, nor did it fail to grow at 39°C (data not shown). On the contrary, 
pre5-ts did not grow at cold temperatures, which is reminiscent of other splicing 
mutants. Conversely, pre1-ts and pre10-ts exhibit phenotypes which are consistent 
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with the ones reported by Ben-Aroya et.al (figure 2B). 
Given the contradiction between the expected phenotype and the one I observed in 
what is now a pre5-cs allele, one needs to be careful in investigating this phenotype 
further. A first step would be to clone out and sequence this allele, and then check if 
insertion in an otherwise wild-type cell reconstitutes the splicing defect. Conversely, if 
the mutation is indeed found at the pre5 locus, one could back-cross the strain to 
ensure that any other putative secondary mutations are selected against. If the splicing 
defect persists, then the phenotype is caused by the mutation in the pre5 allele and is 
not due to some other spurious effect. 
Nevertheless, a couple of other lines of evidence tend to suggest that the splicing 
phenotype that I see in pre5-ts is valid. One is that the genome-wide regulation of 
expression patterns is very similar among the three proteasome mutants I examined 
(figure 3A).  
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Figure A.3: General expression patterns in proteasome mutants 
 
A. Ordering of all exons in the proteasome mutants at permissive and restrictive 
temperatures based on pre5-ts clustering at both 25°C and 37°C. The data is 
shown on a log2 scale. 
B. Comparison of the pre5-ts and snt309∆ exon levels genome-wide reveals little 
similarity 
 155 
C. Expression profiles of all splicing factors in the proteasome mutants. 
 
The ~5200 genes shown in figure 3A are ordered hierarchically by organizing and 
grouping the pre5-ts expression patterns at 25°C and 37°C. As one can see, the 
expression patterns in pre1-ts and pre10-ts closely mirror the ones in pre5-ts, with 
specific genes being highly up- or down regulated in all arrays. Moreover, the 
regulation of different classes of genes within these arrays matches published datasets 
of other proteasome mutants [21]. Thus, genes involved in mating type regulation 
(alpha1, alpha2) as well as a significant proportion of ribosomal protein genes (87 out 
of most 200 down-regulated genes in pre5-ts at non-permissive temperature), are 
generally downregulated in all mutants I examined. Furthermore, expression of genes 
involved in fatty acid metabolism (Ole1, Fas1, Fas2) is decreased in all arrays, 
whereas an increase in expression for catabolism-related and mitocondrial genes is 
observed, similar to published data. In addition, there are clear clusters of genes which 
are similarly regulated at 37°C, and which are most probably involved in the stress 
response at high temperature. In contrast, when I compared the snt309Δ and pre5-ts 
gene expression patterns, these were highly dissimilar (figure 3B). This suggests that 
the pre5-ts mutant, despite being cold sensitive, exhibits the same type of gene 
regulation as other proteasome mutants, suggesting that it might indeed function in the 
same metabolic pathway. 
A second piece of evidence suggests that the splicing defects I observed in the pre5-ts 
mutant are unlikely to be caused by indirect misregulation of the expression of another 
spliceosomal factor (figure 3C). Whereas the U1 and U2 snRNA levels are increased 
in the pre5-ts strain, they are also up-regulated in the pre10-ts mutant, which suggests 
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that the upregulation of these factors is unlikely to cause the general splicing defect 
seen in pre5-ts. In addition, no other factors are increased or decreased more than 2-
fold in pre5-ts alone. However, this does not preclude an indirect effect caused by 
misregulation of protein levels in a splicing factor, which is a concern that will need to 
be addressed. 
Pre5 is thus interesting in that it is a core proteasome subunit which may play a 
separate role in pre-mRNA splicing. Evidence that this is not a global phenotype 
caused by mutations in proteasome components comes from the other two mutants I 
examined pre1-ts and pre10-ts, which do not affect splicing of yeast genes. While the 
proteasome can regulate gene expression indirectly, by down-regulating the levels of 
specific transactivators, it has more recently been shown to associate with the majority 
of yeast genes [21, 23]. Several 19S components were also shown to have roles which 
are independent of the main degradation function. Thus, the Rpt6 subunit of the 19S 
complex was shown to physically interact with FACT1, an elongation factor [24], and 
its depletion inhibited transcription [25]. In addition, the proteasomal ATPases in the 
19S complex facilitate the recruitment of SAGA to yeast promoters [26] and regulate 
the function of mono-ubiquitylated activators [27]. However, these alternative roles 
are independent of the 20S core subunit. To my knowledge, this is the first report of a 
20S α-subunit which might play a separate role in pre-mRNA splicing. 
Lastly, Sem1, a component of the 19S lid subcomplex was shown to form two other 
complexes in which it functions independently of the proteasome [28]. As a part of the 
Sac3-Thp1 complex, Sem1 is involved in pre-mRNA export. Sem1 also associates 
with Csn12, a COP9 signalosome protein which plays a separate role in pre-mRNA 
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splicing. Thus, it is not inconceivable that Pre5 may play a proteasome-independent 
role. While Pre1, Pre5 and Pre10 share several interactors, only Pre5 interacts with 
Sub2 [29] and Sus1 [30] suggesting that it might play a role in coupling splicing to 
pre-mRNA export. However, extensive testing of models must be put off until the true 
nature of the pre5-ts mutation and its phenotype are confirmed. 
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